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CHAPTER 1: GENERAL INTRODUCTION 
Group B Streptococcus: 
Group B Streptococcus (GBS), Streptococcus agalactiae, is a zoonotic pathogen.  
Initially identified as the causative agent of bovine mastitis, in the mid twentieth century 
(1) GBS became the leading cause of neonatal sepsis and meningitis in the developed 
world (2-6).  GBS is commensal in 15-30% of healthy adults, normally as part of the 
vaginal and rectal microflora(7-9).  Neonatal disease can occur via several routes.  First, 
the bacteria can ascend to the uterus and placenta during pregnancy causing 
chorioamnitis (10, 11) and intrautarine infection of the fetus, which can lead to 
premature labor and delivery (12) (13) and stillbirth (14) (13) or the neonate being born 
septic (15). Additionally the infant can aspirate bacteria in the vaginal secretions during 
delivery, leading to sepsis and meningitis. Also during vaginal delivery the infant can 
become colonized by the bacteria (4, 7), which can lead to disease, often later onset 
than the infections resulting from aspiration during delivery.  Breast milk has also been 
implicated in transmission of GBS (3, 4, 16). 
Neonatal GBS disease is divided into those that onset before the seventh day of 
life, called the early onset disease, and those that onset between the seventh day and 
third month of life, called late onset disease.  Late onset disease more often manifests 
as meningitis and can lead to long-term complications including seizures, learning 
disabilities, and deafness. 
Early onset GBS disease can be prevented by treating women during labor and 
delivery with intravenous antibiotics—Intrapartum antibiotic prophylaxis (IAP).  In the 
United States the decision to administer IAP is based on a culture based screening 
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done in the late third trimester (17-19).  European countries administer IAP based on a 
risk based assessment (20, 21).  Both of these strategies lead to inappropriate 
treatment of uncolonized women, and inappropriate lack of treatment of colonized 
women (21).  Colonization is often transient and a culture at 35-37 weeks does not 
always correlate with colonization at delivery (8).  Additionally a culture can be taken or 
handled inappropriately leading to a false culture result.  Further, IAP does not reduce 
the incidence of late onset disease nor of chorioamniosis and pre-labor onset of disease 
(17) (6) (4). 
GBS is not just a neonatal pathogen, it causes disease in immunocompromised 
and older adults as well. (22) (23) (24). 
Capsule production:  
Production of a polysaccharide capsule is an important virulence factor of GBS 
(25, 26).  The capsule protects the bacteria from complement deposition and 
opsonophagocytic killing.  GBS has 10 capsule serotypes (Ia, Ib and II-IX) resulting in 
polysaccharides of different sugar composition and chain length (27, 28).  The gene 
products encoded by the cps locus determine the serotypes.  The first four genes of the 
locus cpsA-D are highly conserved across all serotypes.  CpsA is a transcriptional 
activator, CpsB dephosphorylates CpsD, CpsC phosphoryates CpsD and the CpsD 
phosphorylation state controls polysaccharide chain length.  The other genes of the 
locus encode serotype specific glycosyltransferases.   
Capsule assembly is similar to assembly of peptidoglycan of all bacterial species 
and the O-polysaccharide of Gram-negative lipopolysaccharide (LPS) (29-31).  
Polysaccharide subunit assembly begins on the cytoplasmic face of the bacterial 
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plasma membrane by a series of glysosyltransferases.  The growing polysaccharide is 
flipped to the outer face of the bacterial membrane by a Wzx family flippase (32).  
Polysaccharide subunits are linked to each other by a Wzy family polymerase.  In 
Gram-negative organisms O-antigen is ligated to the core polysaccharide and lipid A 
components of LPS by WaaL (30).  Capsule is ligated to the cell wall by an as of yet 
unknown enzyme.  During this whole process the polysaccharide precursors are linked 
to undecaprenyl- pyrophosphate as a lipid carrier.  Undecaprenyl-PP is 
dephosphorylated and then moves back to the inner leaflet of the membrane for 
recycling.  Breakdowns in this process can lead to growth arrest, cell death and cell wall 
abnormalities (33). 
LCP Proteins: 
The LCP (LytR-Psr-CpsA) family of proteins is found in multiple Gram-positive 
bacterial species (34).  These proteins are important for proper cell envelope 
carbohydrate expression and cell wall integrity (35).  Control of cell envelope 
carbohydrate (capsule and teichoic acids (36)) expression is key for virulence and cell 
wall integrity is key for bacterial survival and proliferation in the host environment. 
These proteins are all integral membrane proteins with one or more 
transmembrane domains.  They share a common extracellular domain called the LCP 
domain (34).  This domain has been implicated for a role in attachment of cell envelope 
polysaccharides to the peptidoglycan cell wall (35).  
CpsA: 
CpsA is a member of the LCP family of proteins.  A unique feature of CpsA is 
that, in addition to the extracellular LCP domain, it also contains an additional 
 4 
 
extracellular domain, the accessory domain, not found in any of the other LCP family 
members.  Previous work had identified this domain by its homology to the DNA 
polymerase processivity factor (DNA_ppf) of phage and eukaryotic DNA polymerases. 
(34, 37, 38).  However, the limited homology and extracellular localization of the 
accessory domain indicate that it does not serve a role in DNA  replication and instead 
serves another function in the CpsA protein. The accessory domain of the 
Streptococcus pneumoniae Cps2A protein folds independently from the LCP domain 
(35).  The high homology between the pneumococcal and GBS CpsA (50% identical 
and 69% similarity at the amino acid level) supports that in GBS as well the accessory 
domain is an independently folding and functioning domain.  However, homology 
between the pneumococcal and GBS proteins is least similar in the accessory domain, 
indicating that the accessory domain could serve different functions in the two different 
species of bacteria. 
The CpsA protein is widespread across many streptococcal species.  There is a 
high degree of conservation between the CpsA proteins of the pathogenic S. 
pneumoniae, S. iniae, S. agalactiae and the non-pathogenic S. thermophilus. 
CpsA of S. pneumoniae has been implicated in regulation of expression of cps 
locus genes and in virulence.  Deletion of cps2A leads to a reduction in the amount of 
capsule expressed by the bacteria, and reduction in the proportion of phosphorylated 
CpsD (39, 40), which is important for full activity of CpsD in export of capsule precursor 
subunits to the extracellular surface of the bacteria (41).  S. pneumoniae strains that are 
more invasive have higher expression of cpsA in in vitro growth, indicating that cpsA 
has a role in virulence in invasive infections. (42).  Additionally, expression of cps2A is 
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four fold upregulated 12 and 24 hours post infection in mouse models of disease 
compared to growth in broth culture (43).  Growth in serum containing media or whole 
mouse blood also leads to an upregulation of cps2A production compared to growth in 
Todd-Hewitt Yeast (THY) broth (43), indicating a virulence function of cps2A. Proper 
regulation of cps gene expression is also critical for invasive infection by S. 
pneumoniae.  Ectopic expression of the cps locus from a constitutively strong or weak 
promoter caused attenuation of colonization and virulence in animal models (44). 
CpsA of the zoonotic fish pathogen Streptococcus iniae has roles in capsule 
expression, virulence and transcription of the cps locus genes (37, 45-47).  A virulence 
screen for S. iniae mutants attenuated in a zebrafish model of disease identified several 
genes in the cps locus (45). A S. iniae strain with an insertion mutation in cpsA had 
reduced capsule expression and reduced lethality and ability to disseminate to major 
organs in a zebrafish model of systemic disease (46).  This mutant also had reduced 
lethality in a zebrafish larvae infection model (47). Further, this mutant had reduced 
promoter activity from the cpsA promoter in a reporter assay (unpublished data, Neely 
lab).  Full length purified CpsA of S. iniae was shown in vitro to be capable of specific 
binding to the cpsA promoter, while C-terminally truncated purified CpsA was capable of 
binding the cpsA promoter, but with no specificity (37).  This supports the role of CpsA 
as a transcriptional activator responsible for capsule expression and virulence. 
CpsA of GBS has been implicated in transcriptional activation of the cps locus 
(48).  Deletion of cpsA leads to a reduced amount of capsule production by GBS, and to 
decreased transcription of cps locus genes (48).  Later analysis of GBS CpsA (38) 
demonstrated a bifunctional role for CpsA in capsule expression and cell wall stability.  
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Deletion of cpsA led to a reduction in capsule expression and to the bacteria forming 
unusually long chains of cocci.  Additionally, episomal expression of a truncated CpsA 
missing the most C-terminal extracellular LCP domain caused a dominant negative 
effect when expressed in the wild type strain, resulting in decreased capsule expression 
and increased chain length (38).  This indicated that the extracellular domains of CpsA 
were key to both the capsule expression and cell wall maintenance functions of CpsA.  
Analysis of full length and truncated CpsA binding to the two promoters of the cps locus 
showed that full length CpsA is capable of specific binding to the promoters, whereas 
truncated CpsA missing the extracellular domain is capable of binding, but with reduced 
specificity.  This suggested that the extracellular domain is serving a role in 
transcriptional regulation of this locus, through promoting proper conformation of CpsA 
to lead to specific DNA binding (38). 
Streptococcus pyogenes: 
Streptococcus pyogenes is a human pathogen.  Infections caused by S. 
pyogenes range from superficial and self-limiting impetigo and pharyngitis to systemic 
and life threatening manifestations such as scarlet fever and necrotizing fasciitis.  
Immune responses to S. pyogenes can lead to long term sequelae such as rheumatic 
heart disease and glomerulonephritis.   
Rare among human pathogens, S. pyogenes is as sensitive today to beta-lactam 
antibiotics as when penicillin was first introduced.  However, resistance to macrolides is 
emerging.  Macrolides are the antibiotics of choice when a patient is allergic to penicillin, 
or in a mixed bacterial infection, when other species are, or are likely to be, beta-lactam 
resistant.  Further, the most severe manifestations of S. pyogenes infection, necrotizing 
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fasciitis and streptococcal toxic shock syndrome, respond only to the highest doses of 
antibiotics, if at all. 
Virulence of S. pyogenes is a dynamic process, with the bacteria modifying its 
transcriptome to survive and proliferate in a host while evading the host immune 
system.  During necrotizing fasciitis, an influx of phagocytes to the site of infection is 
somehow prevented by the bacteria (49).  In a mouse model of soft-tissue infection the 
most highly expressed transcripts are involved in stress adaptation and cellular 
remodeling, including known virulence determinants (50). Two-component signaling 
systems (TCSS) are involved in transcriptional regulation in bacteria, and are potential 
drug targets against pathogenic bacteria (51).  
The salivaricin locus of S. pyogenes: 
Previous work in our lab identified an operon important for development of 
systemic disease by S. pyogenes (52, 53).  This locus had homology to the lantibiotic 
production locus of the oral commensal Streptococcus salivarius (54). In S. salivarius 
the gene products of this locus are responsible for the production and export of and 
immunity against a bacteriocin-like inhibitory substance, salivaricin A (55).  This peptide 
contains unique intrapeptide bridges resulting from the dehydration of amino acids (56-
58).  These lanthionine bridges give this class of bacteriocins the name lantibiotics.  
Against other Gram-positive bacteria, salivaricin A acts as a pore-forming toxin (59-61).  
This is important for establishment of a niche in the competitive environment of the oral 
microflora.  Most strains of S. pyogenes do not produce an active lantibiotic from this 
locus (54, 60). However, all sequenced strains of S. pyogenes do maintain this locus.  
Due to the flexibility of the S. pyogenes genome, maintenance of this locus across all 
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strains indicates that this locus has been repurposed for a critical role in S. pyogenes.  
Our data showing that mutations in this locus cause attenuation of virulence suggests 
that the role of the salivaricin locus in S. pyogenes is in virulence (52, 53). 
The salivaricin locus contains a two component signaling system SalKR and two 
peptides at either end of the locus SalA and SalZ.  Because S. pyogenes does not have 
alternative sigma factors it relies on two-component signaling systems, 13 of which 
have been identified in the genome, to cause global transcription changes.  Two-
component signaling systems have a sensor kinase (in this case SalK) which 
autophosphorylates in response to environmental signals.  SalK then phosphorylates 
the response regulator (in this case SalR) which functions as a transcriptional regulator 
to cause changes in expression of target genes.  Peptides serve as important signaling 
molecules in many species of bacteria (62).  SalA serves as the lantibiotic in S. 
salivarius causing killing of bacteria that do not produce SalA, but it also serves as a 
quorum-sensing molecule and is sensed by SalK to upregulate transcription of the sal 
locus genes (60).  This causes a positive feedback loop to produce more SalA peptide, 
but also serves as a way to induce production of the immunity genes. 
SalA of most strains of S. pyogenes is not an active lantibiotic (54).  This is due 
to mutation of the modification and export genes, salM and salT respectively, leading to 
premature stop codons and truncated non-functional proteins being produced from 
these genes.  So, SalA is not modified into a lanthionine containing peptide, but still 
could be serving a role in peptide signaling.  SalZ is a 66 amino acid peptide of 
unknown function found at the 3’ end of the operon. Peptides serve an important 
signaling role in many species of bacteria.  In many Gram-positive species ribosomally 
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synthesized and non-ribosomally synthesized peptides serve as quorum sensing 
molecules (63-65).  Bacterial peptides can also serve as a role in transcription as co-
repressors (66).  Peptide sigalling serves a key role in sporulation of Bacillus species 
(67, 68).  This supports a role for the peptides of the sal locus to be serving a signaling 








Group B Streptococcus (GBS), Streptococcus agalactiae, is a broad host range 
pathogen capable of causing severe sepsis and meningoencephalitis in fish (69-74), 
bovine mastitis (75-77), human neonatal sepsis and meningitis (1-6) and has been 
recently implicated in chorioamnitis (10, 11) causing premature birth in humans (12, 13) 
and stillbirth (13, 14).  GBS also can cause a range of invasive infections in 
immunocompromised and older adults (22-24). However, GBS is also capable of 
existing as a commensal of the human vaginal and rectal mucosa (9, 78, 79).  
The current strategy to prevent GBS infection of neonates is intrapartum 
antibiotic prophylaxis (IAP) (17), intravenous antibiotics given to a woman during labor 
and delivery. IAP is administered either to women following positive GBS culture during 
prenatal screening (17, 19), or if risk based criteria are met (20, 21). This has led to a 
reduction in incidence of GBS disease in the first week of life (early onset disease) but 
has not changed the incidence of GBS disease in the first three months of life (late 
onset disease) (4, 6, 17). 
One mechanism allowing bacteria to successfully function as both a commensal 
and a pathogen is regulation of polysaccharide capsule expression.  This is an essential 
event for GBS immunoevasion and survival in the bloodstream (25), but not essential 
for colonization, as a GBS isolate with a complete deletion of the cps locus is capable of 
colonizing the vaginal mucosa (80).  GBS has ten serotypes defined by the genes of the 
cps locus, leading to different polysaccharide compositions (27).   The first regulatory 
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gene of this locus, cpsA, is conserved across all serotypes and plays a role in 
transcriptional activation of this locus (48). 
CpsA is a member of the LCP (LytR-CpsA-Psr) protein family.  These are found 
in a broad range of Gram-positive bacterial species (34) and are important for linkage of 
cell wall carbohydrates to the cell wall, cell wall maintenance and cell division (35).  Cell 
wall stability and proper control of cell division are important for bacterial survival and 
proliferation in the stressful environment of the host.  LCP family proteins have one or 
more transmembrane domains and a large extracellular domain containing the 
conserved LCP domain (34), which is hypothesized to have a catalytic function (35).  
The CpsA protein, however, is unique among the family of LCP proteins as in addition 
to the extracellular LCP domain; it possesses an additional extracellular domain, called 
the accessory domain.  
Analysis of the GBS CpsA protein (38) demonstrated a bifunctional role for CpsA 
in capsule expression and cell wall stability.  Deletion of the cpsA gene led to a 
reduction in capsule production and to the bacteria forming unusually long chains of 
cocci.  Additionally, episomal expression of a truncated CpsA protein missing the most 
C-terminal (LCP) extracellular domain caused a dominant negative effect when 
expressed in the wild type strain, resulting in decreased capsule production and 
increased chain length (38).  This indicated that the extracellular domains of the CpsA 
protein were important for both the capsule expression and cell wall maintenance 
functions.  Analysis of full length and truncated CpsA proteins binding to the two 
promoters of the cps locus showed that full length CpsA is capable of specific binding to 
the promoters, whereas truncated CpsA missing the extracellular domain is still capable 
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of DNA binding, but with reduced specificity.  This suggested that the extracellular 
domain is serving a role in transcriptional regulation of this locus, through promoting 
proper protein conformation of CpsA for specific DNA binding (38). 
Previous analysis of GBS CpsA protein function revealed that episomal 
expression of the CpsA-Full protein in an isogenic cpsA deletion strain could 
complement the cpsA deletion for wild type capsule expression (38).  Surprisingly, 
episomal expression of a truncated CpsA with the entire extracellular domain removed 
(CpsA-117, figure 1), was also able to complement in vitro to wild type capsule levels.  
However, expression of a truncated form of CpsA in which only the extracellular 
accessory domain remained (CpsA-245, figure 1) could not complement for capsule 
production in the cpsA deletion strain (38).  Therefore, while the extracellular domain of 
CpsA is not needed for capsule production in vitro, expressing only the extracellular 
accessory domain in the absence of the LCP domain results in an inability to 
complement for capsule production.  Episomal expression of these same protein 
constructs in the wild type GBS strain had quite different results.  While the CpsA-Full 
and the CpsA-117 proteins had no effect on wild type capsule expression, episomal 
expression of the CpsA-245 protein caused a dominant negative effect on capsule 
production, effectively inhibiting the ability of the wild type strain to produce capsule 
even in the presence of the wild type CpsA protein (38).  
In this study we have identified the regions of the extracellular accessory domain 
of the GBS CpsA protein that are required for the dominant negative effect. 
Furthermore, we determined that the dominant negative phenotype could be induced by 




Figure 1: The GBS CpsA protein:  A) Membrane topology of CpsA. B) Domains of 




Visualization of peptide binding revealed that this region of CpsA is in contact 
with the midcell septal region of the bacterial cell wall. Additional cell wall integrity 
defects were demonstrated in strains with a deletion of cpsA and a strain expressing a 
truncated form of the CpsA protein.  Lastly, we provide evidence that deletion of the 
cpsA gene or expression of a truncated CpsA protein leads to attenuation of virulence. 
Materials and Methods: 
Bacterial strains and growth conditions: 
Escherichia coli strains TOP10 and Electromax DH5α (Invitrogen) were used for 
construction and maintenance of plasmids.  They were grown in aerobic conditions with 
shaking in liquid LB (Acumedia) or aerobically on LB agarose plates: LB supplemented 
with 1.5% technical agar (Acumedia) and supplemented with antibiotics at 
concentrations of:  Ampicillin 100 µg/mL, Chloramphenicol 20 µg/mL or Erythromycin 
750 µg/mL.   
Streptococcus agalactiae strain 515 and the isogenic cpsA mutant (48) were 
grown statically in closed tubes in Todd Hewitt media (Alpha Biosciences) + 0.2% yeast 
extract (Acumedia) (THY) with the addition of 1.4% bacteriological agar (Acumedia) for 
solid media, and grown anaerobically or in 5% CO2, and supplemented with antibiotics 
at concentrations of: Chloramphenicol 3µg/mL or Erythromycin 2 µg/mL.  Cultures 
grown in the presence of purified protein or synthetic peptide were grown in media 
supplemented with HALT Protease Inhibitor cocktail (ThermoFisher). 
The CpsA-insert strain was constructed using primers 5’ GBS cpsA insert PstI 
and 3’ GBS cpsA insert XmaI (see table1) by amplifying a 454 bp fragment using GBS 
515 genomic DNA as template.  Purified fragment was cloned into the PstI and XmaI 
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sites of vector pUC19-Erm (45). Plasmid was transformed into GBS strain 515 and 
single crossover recombinants selected by plating on THY Erm 2µg/mL agarose plates. 
CpsA truncations were made using a template encoding an MBP-cpsA (plasmid 
pGBS cpsA-full (38)) using primers 5’ MBP RBS BamHI (see table1) and 3’ primer 
depending on truncation (see table1), and cloned into vector pLZ12-rofA for constitutive 
expression. Plasmids were transformed into GBS strain 515 and its isogenic ΔcpsA 
derivative as previously described (38). 
Percoll buoyant density centrifugation: 
Buoyant density was determined using linear Percoll (GE Healthcare) gradients 
as previously described (38).  Briefly, 2mL Percoll, supplemented with 0.15M NaCl, 
diluted to low (1.085 g/cm3) density was carefully overlaid onto 2mL Percoll diluted to 
high (1.120 g/cm3) density in a 5mL tube and placed at a 15° angle overnight to allow 
formation of a continuous linear gradient.  Gradients were placed vertically and allowed 
to settle at least 30 minutes prior to use.  Overnight bacterial cultures were normalized 
to an OD600=0.6 and concentrated to a volume of 50µL in phosphate buffered saline.  
Culture was carefully added to top of gradient and gradients were centrifuged 30 min at 
room temperature and 5,000 rpm in a swinging bucket (Eppendorf Centrifuge 5403 with 
Rotor 16A4-44).  Distance traveled in the gradient was measured from the bottom of the 
meniscus to the center of the cell band, and density was determined by calculation of a 
linear curve from distance traveled by beads of known density (GE Healthcare). 
Protein purification: 
Proteins were purified using the pMal-c2x system (NEB) as previously described 
(38). Elution fractions containing protein were detected by the BCA assay (Pierce) and  
 16 
 
Table 1: Primers used in Chapter 2 
 
Primer name Sequence (restriction site underlined) 
5’ GBS cpsA-insert PstI AAAACTGCAGCGTTGCTACTACTTTATATGG 
3’ GBS cpsA-insert XmaI TCCCCCCGGGGTATCAATACCGCTAAATAG 
5’ MBP RBS BamHI CGCGGATCCGCGGATAACAATTTCACACAGG 
3’ GBS cpsA full PstI AAAACTGCAGTTATTCCTCCATTGTGTTC 
3’ GBS cpsA 245 PstI AAAACTGCAGTTATGTTGATATAGAGCCAAAAG 
3’ GBS cpsA 210 PstI AAAACTGCAGTTAAATCGTTTTTATCTGCG 
3’ GBS cpsA 187 PstI AAAACTGCAGTCATAAAACCATAGCCTGACTATC 
3’ GBS cpsA 153 PstI #2 AAAACTGCAGCATTCTATCAAATCAGTAATATTTC AG 
3’ GBS cpsA 132 PstI AAAACTGCAGTCAAGCTTCTATATTGG 






were examined by SDS-PAGE to determine protein purity and integrity.  Fractions were 
concentrated as necessary with a 50 kDa centrifugal concentrator (Millipore) and stored 
at -80˚C in 50% glycerol. 
CpsA peptide generation and labeling: 
  CpsA peptide: INRKNTNHKEGVFNIYISGITDTF was synthesized (GenScript) 
and resuspended in sterile double distilled water at a concentration of 2 mg/mL.  
Peptide was labeled with Fluorescein isothiocyanate (FITC) To 192 μL of peptide 
(2mg/mL) in 568 μL carbonate-bicarbonate buffer (0.1 M, pH 9.0), 40 μL of freshly 
prepared fluorescein-5-isothiocyanate stock solution (16 mM in DMF) was added and 
the reaction was incubated in a 37 oC rotary shaker for 3 h. The reaction mixture was 
loaded onto a 5 mL Sephadex G-25 column and the column was washed with deionized 
water while collecting fractions. Each fraction was monitored at 280 nm and 495 nm and 
fractions containing both absorbance values were combined and lyophilized. The 
resulting orange powder was re-dissolved in water and the concentration of labeled 
peptide was calculated using equation C= (A280 – A495 x 0.35)/128 where C is the 
peptide concentration (M), A280 and A495 are the absorbance at 280 nm and 495 nm, 
respectively. 
Microscopy: 
Phase contrast microscopy was performed on overnight cultures of wild type 
bacteria grown in the presence or absence of 200 pmol/mL unlabeled CpsA peptide. 
Five microliters of overnight culture was mounted with a coverslip and observed using a 
Zeiss Axioscope 40 and imaged with Axiovision 4.7. 
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Cultures were grown in the presence of FITC-labeled peptide overnight at 
concentration indicated and normalized to an OD600 of 1.0, followed by three washes in 
phosphate buffered saline (PBS). Five microliters of washed bacteria were observed as 
a wet mount using a Zeiss Axioscope 40 and imaged with Axiovision 4.7.  For 
competitive binding analysis cultures were grown overnight in the presence of 2.5 
µg/mL FITC-labeled peptide with or without a 25 fold molar excess of unlabeled peptide.  
Cultures were normalized to an OD600 of 1.0, followed by three washes in phosphate 
buffered saline (PBS). Fluorescence of a 100 µL sample in triplicate was read in a 
Tecan Spectrafluor Plus Fluorometer with Magellan6 software using the fluorescein 
default settings. 
Fluorescent vancomycin staining was performed on midlog cultures.  Bacteria 
were grown overnight and then subcultured 1:50.  At midlog (OD600=0.3) cultures were 
concentrated to OD600=1.0.  Ten microliters of culture and a final concentration of 
1µg/µL BODIPY_FL vancomycin (Life Technologies) were incubated 10 minutes at 
37˚C to allow incorporation of stain into newly formed cell wall.  Cultures were then 
washed 3 times in PBS and then were resuspended in 3µL PBS and observed as a wet 
mount using a Zeiss Axioscope 40 and imaged with Axiovision 4.7. 
Virulence Assays: 
Human whole blood infections were performed as described previously (38) 
Briefly, blood was freshly isolated from healthy volunteers and collected in heparinized 
vacuum tubes (BD).  Bacterial cultures were grown to midlog and washed in phosphate 
buffered saline.  Bacteria were inoculated at a dose of 2X105 cfu per mL blood in 
triplicate in 1.5 mL tubes (Dot Scientific) with end over end rotation for 3 hours at 37˚C.  
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Bacteria were plated on THY agarose plates in duplicate and viable cfu enumerated.  
Log killed was determined from plating the inocula and subtracting the log of the product 
cfu from the log of the inoculum cfu. 
Zebrafish infections were performed as described previously (81). Briefly, adult 
zebrafish were injected intramuscularly with midlog bacterial cultures at an infectious 
dose of 106 cfu per fish. For dissemination analysis, fish were sacrificed at 24 hours and 
viable cfu in the brain, heart and spleen were determined by plating on CNA selective 
agar (Acumedia).  
 Results: 
CpsA-insert mutant: 
To further investigate the function of the extracellular accessory domain of the 
GBS CpsA protein, a non-polar cpsA insertion mutation on the chromosome was 
constructed and tested for the ability to produce capsule. This mutant strain expresses a 
truncated form of the CpsA protein, missing the C-terminal extracellular LCP domain 
(similar to the CpsA-245 truncation, figure 1).  Buoyant density analysis revealed that 
the CpsA-insert strain produces capsule levels even further reduced than those of the 
cpsA deletion strain (figure 2). These results, coupled with our previous data using the 
episomally expressed CpsA-245 protein in the wild type GBS strain as described above, 
suggest that the CpsA extracellular accessory domain, when in the absence of the LCP 




Figure 2: Capsule production.  Measurement of capsule production of the GBS wild 
type, the ΔcpsA and the cpsA-insert strains as measured by Percoll buoyant density 







Figure 3:  Capsule production by strains with episomally expressed CpsA 
truncations.  Capsule production measured by Percoll buoyant density centrifugation. 
Notations on left indicate CpsA version expressed from a plasmid in the indicated strain. 
Black columns represent the wild type strains expressing the indicated construct.  Grey 
columns represent the ΔcpsA strains expressing the indicated construct. Densities were 
normalized to wild type with empty vector.   ** significantly (p<0.01) different from wild 





Extracellualar domain truncation: 
To narrow down the region of the accessory domain responsible for the dominant 
negative effect, serial truncations of the extracellular domain of the CpsA-245 protein 
were made (see figure 1).  These constructs were expressed episomally in the wild type 
strain and the ΔcpsA strain (figure 3).  Only the CpsA-117 and CpsA-full were able to  
complement the cpsA deletion strain.  The CpsA-210, CpsA-187 and CpsA-132 when 
expressed episomally in wild type had wild type capsule levels, and the CpsA-153 had 
reduced capsule level, commensurate with the cpsA deletion and the episomally 
expressed CpsA-245 (figure 3).  These results indicate that the dominant negative effect 
is accomplished by an aberrant function or interaction occurring with the regions of 
CpsA from amino acids 153-187 and 210-245 with itself and/or other binding partners. 
Addition of purified protein: 
We next questioned if the dominant negative phenotype caused by expression of 
the CpsA-245 protein in the presence of the wild type CpsA protein (wild type strain) 
could exert its inhibitory effect if added exogenously or if it needed to be produced by 
the bacteria.  Therefore, purified proteins of various CpsA truncations were added to a 
culture of wild type bacteria and assessed for capsule production by buoyant density 
centrifugation (figure 4). Addition of purified CpsA-117 protein and the CpsA-full protein, 
which had no effect on capsule levels when expressed episomally in the wild type strain 
(figure 3), also had no effect on capsule levels when supplied as purified proteins to the 
cultures (figure 4).  However, addition of purified CpsA-245 protein, which causes a 
dominant negative effect on capsule levels when expressed episomally in the wild type 




Figure 4: Capsule production in the presence of purified protein.  Capsule 
production measured by Percoll buoyant density centrifugation.  Cultures were grown 
with the indicated protein at a concentration of 20 pmol/mL, in the presence of protease 




culture of wild type bacteria.  As a negative control, cultures were grown with the 
purified SalR protein, a Streptococcus pyogenes protein constructed and purified by the 
same process and had no effect on capsule expression.  Therefore, the dominant 
negative phenotype caused by expression of the CpsA-245 protein is capable of 
causing the same result when added exogenously. 
Addition of CpsA peptide: 
The serial truncations of the extracellular domains determined that the most C-
terminal end of the accessory domain was important for the dominant negative effect.  
Therefore, the CpsA peptide, a synthetic peptide corresponding to amino acids 218-240 
was constructed.  When wild type cultures were grown in the presence of the CpsA 
peptide, capsule production was significantly reduced (figure 5).   However, addition of 
the unrelated Streptococcus pyogenes SalA peptide, of similar size and synthesized by 
the same process, had no effect on capsule production.  These results further confirm 
the ability of the dominant negative factor to function from the extracelluar environment. 
Moreover, these results demonstrate that the N-terminal DNA binding and 
transmembrane domains of the CpsA protein are not required for the dominant negative 
effect to occur. 
Previous analysis of cpsA mutations or episomal expression of truncated forms 
of the CpsA protein revealed that in addition to changes in capsule production there 
were also changes in cell wall architecture as evidenced by the formation of unusually 
long chains of cocci in these strains (38).  Addition of the CpsA peptide to wild type 




Figure 5: Capsule production in the presence of CpsA peptide.  Capsule production 
measured by Percoll buoyant density centrifugation. Cultures were grown with the 
indicated peptide at a concentration of 200 pmol/mL of in the presence of protease 
inhibitors. *p<0.05 **p<0.01.  
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Figure 6: Effect of peptide on chain length. Phase contrast microscopy of overnight 
cultures of wild type bacteria grown in the presence of protease inhibitors (A) in the 








chains being greater than 10 cocci per chain (Figure 6B). To visualize the interaction of 
the peptide with the bacteria and any cell wall changes that may be occurring, the 
peptide was labeled with FITC and examined by fluorescence microscopy (figure 7).  
When GBS cultures were grown in the presence of the FITC-labeled peptide, nearly 
identical staining patterns were apparent in both the wild type (figure 7A) and ΔcpsA 
(figure 7B) cultures indicating that the peptide is binding to a factor other than the CpsA 
protein.  Both wild type and cpsA deletion strain cultures exhibited a long chain  
phenotype, indicating that the peptide is able to exert a dominant negative effect on the 
cell wall, similar to the episomal expression of CpsA-245 leading to the bacteria forming 
long chains of cocci (38).  Staining was most intense at the midcell of the bacteria and 
the region of the division septae suggesting that peptide interactions are located at the 
division septum, potentially as part of the cell division machinery.  When FITC-peptide 
was incubated with cells in the absence of growth no binding was visualized (data not 
shown) indicating actively growing cells are required for peptide binding.   
To determine if the binding of FITC-peptide to the bacteria was specific, 
competition experiments were performed.  Bacteria were grown in the presence of the 
FITC-labeled peptide, or labeled peptide plus an excess of unlabeled peptide. Relative 
fluorescence units (RLU) were determined using a 96-well fluorometer and compared 
between the two conditions.  The wild type culture and the cpsA-deletion culture with 
both labeled peptide and a 25-fold excess of unlabeled peptide exhibited 5.25 ± 1.4 and 
6.12 ± 1.21 fold less florescence, respectively, when compared to the fluorescence of 





Figure 7: Localization of FITC-labeled CpsA peptide.  Fluorescent micrographs of 
(A) wild type and (B) ΔcpsA bacteria grown overnight in the presence of FITC-labeled 






Fluorescent Vancomycin staining: 
In an effort to examine the cell wall effects caused by CpsA protein truncation, 
actively growing bacteria were pulse-labeled with BODIPY-FL vancomycin (figure 8).  
The mechanism of action of this compound is the staining of newly synthesized, but not 
yet cross-linked cell wall to show areas of active cell wall assembly.  Wild type (figure 
8A) and cpsA deletion (figure 8B) strains exhibited clear rings of cell wall around each 
individual coccus, with some increased thickness at the division septae.  CpsA-insert 
bacteria (figure 8C) exhibited cocci of uneven size, and unequal staining intensity, 
indicating differences in cell wall thickness in different regions of the bacteria.   
Additionally, some cocci appear to have multiple division septae forming, indicating an 
aberrant cell division event.  Wild type bacteria episomally expressing the CpsA-245 
protein exhibited unequal cell wall staining and evidence of multiple division septae 
forming per cell (figure 8D). The cpsA deletion strain episomally expressing the CpsA-
245 protein (figure 8E) appears similar to the CpsA-insert strain, with cocci of uneven 
size and uneven cell wall thickness, and multiple division septae per cell.  These results 
demonstrate that expression of the truncated CpsA protein leads to changes in cell wall 
morphology and cell division, perhaps through aberrant protein interactions.  In the case 
of the wild type strain expressing the CpsA-245 protein truncation, which expresses 






Figure 8: Fluorescent Vancomycin staining of newly formed cell wall. (A) WT 
strain, (B) ΔcpsA strain, (C) cpsA-insert, (D) WT/pCpsA-245 and (E) ΔcpsA/pCpsA-245. 





The importance of the CpsA protein, particularly the extracellular domains, in 
promoting bacterial survival in human whole blood was analyzed using the various 
CpsA mutated strains.  While the wild type and cpsA deletion strains were killed to  
similar levels, the CpsA-insert strain exhibited a half log less survival after three hours in 
blood (figure 9).  This indicates that the capsule and cell wall deficits caused by the 
aberrant function of the accessory domain have virulence consequences in preventing 
bacterial survival in human blood. 
The role of the CpsA protein in virulence in a zebrafish sepsis-meningoencephalitis 
model was also examined.  Fish were injected intramuscularly and assayed for bacterial 
dissemination to the heart, spleen and brain 24 hours post infection (figure 10).  The 
cpsA deletion strain was attenuated in the ability to disseminate to the heart and brain, 
while the cpsA-insert strain was attenuated in the ability to disseminate to all three 
major organs.  Moreover, the ability of the cpsA-insert strain to disseminate to the heart 
and brain was significantly reduced from that shown for the cpsA deletion, further 
supporting the key detrimental effect of the aberrant function of the accessory domain of 
CpsA in virulence of GBS allowing dissemination away from the initial site of infection 




Figure 9: Human whole blood bactericidal assay.  Log bacteria killed in three hours 
in freshly isolated heparinized human whole blood.  Trend representative of four 
independent experiments. Error bars are standard deviation of three technical 






Figure 10: GBS dissemination to zebrafish major organs.  Measurement of viable 
cfu in spleen, heart and brain of individual zebrafish 24 hours post 106 cfu intramuscular 
injection.  Each point is one fish, bar indicates mean. *p<0.05, **p<0.01 different from 






LCP (LytR-CpsA-Psr) family members are found in a variety of Gram-positive 
bacteria and have been credited with a wide range of functions and phenotypes.  
However, mechanisms of how most of these proteins function are as yet undetermined.  
Recently, LCP proteins have been implicated in the attachment of cell wall 
carbohydrates, capsule and teichoic acids, to the cell wall (35, 82, 83).  Cell wall 
carbohydrate precursors are made processively on the inner and then the outer leaflet 
of the bacterial membrane.  The carbohydrate precursors are anchored to lipid carriers 
during this process.  LCP family members are hypothesized to act enzymatically to 
transfer the precursors off of the lipid carrier and onto the peptidoglycan cell wall with 
some substrate specificity, but can compensate for each other singly mutated (35, 82, 
83).  A Staphylococcus aureus triple mutant in three LCP family members has no wall 
teichoic acids, releasing teichoic acid instead into the culture supernatant (84).  A 
double mutant of Streptococcus pneumoniae in two LCP family members releases 
capsule into the culture supernatant (82).  Mutation of multiple LCP family members can 
be lethal (85) or cause growth deficits unless compensatory mutations of other genes 
also occur (35, 82, 86, 87).   
The CpsA protein is a member of the LCP protein family and is highly conserved 
in all GBS strains and serotypes.  As mentioned above, the CpsA protein contains an 
additional extracellular domain, called the accessory domain, that is not found in the 
other LCP family members.  Notations in the genomic databases identify this domain by 
its homology to the DNA polymerase processivity factor (DNA_PPF) of phage and 
eukaryotic DNA polymerases.  However, the homology is quite limited and this domain 
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is found on the outside of the cell and, therefore, not likely to play a role in DNA 
replication. Analysis of the crystal structure of the extracellular domains of the 
Streptococcus pneumoniae Cps2A protein reveals that the accessory domain folds 
independently of the LCP domain (35).  There is high homology between the 
pneumococcal and GBS CpsA proteins (50% identical and 69% similarity at the amino 
acid level), suggesting conserved topology.   
Previous work with ectopic expression of extracellularly truncated GBS CpsA 
protein identified a dominant negative effect on capsule expression when the CpsA-245 
protein, (containing only the accessory domain in the absence of the LCP domain) was 
expressed in the wild type strain (38). Additionally, ectopic expression of this truncation 
caused abnormal cell wall phenotypes leading to the production of long chains of cocci.  
However, episomal expression of the CpsA-full protein or the CpsA-117 protein did not 
cause a dominant negative effect on capsule or cell wall phenotypes. These results 
indicate that the accessory domain, in the absence of the LCP domain, resulted in 
aberrant function with a decrease in capsule production and cell wall integrity. Serial 
truncations constructed in this study identified two regions of the accessory domain that 
are key to the dominant negative effect. 
A dominant negative effect can occur when a mutant copy of a protein interferes 
with the function of the wild type protein.  This can be accomplished through direct 
interaction of the mutant copy with the wild type protein, thereby blocking function, or 
through the interaction of the mutant copy of the protein with the normal binding 
partners or substrates required for proper function of the wild type protein.  In the case 
of the CpsA protein, we demonstrated that the dominant negative effect occurs through 
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expression of the protein episomally from within the cell, or exogenously by adding a 
purified truncated CpsA protein or synthetic CpsA peptide to the extracellular 
environment. The demonstration of the fluorescent peptide binding to both the wild type 
and the cpsA deletion bacteria indicates that the dominant negative effect is not 
produced by direct interaction with wild type CpsA protein. The ability of addition of 
truncated purified protein or synthetic peptide to induce a dominant negative effect 
when added to culture, without requiring cellular expression of the mutant protein 
supports a scenario in which the accessory domain/peptide interferes with mechanisms 
required for the normal cell wall integrity and capsule production. 
Disruption of LCP family proteins leads to cell wall and cell division abnormalities 
in multiple bacterial species.  In Streptococcus mutans mutation of the LCP family 
member brpA led to abnormal cell division events and atypical cell wall morphology (85, 
88).  S. mutans lytR mutants also have disregulated cell division leading to the 
formation of long chains of cocci (89).  Staphylococcus aureus triple lcp mutants have 
unusually thin cell walls and aberrantly located division septae (84, 87) and are 
hypersensitive to the cell wall targeting antimicrobials bacitracin (86) and oxacillin (90).  
Mutation of the S. aureus msrR gene, encoding an LCP family member, causes cells to 
be unusually large and have misplaced division septae (91).  Double LCP mutants in 
Streptococcus pneumoniae grew more slowly and had cell division septae placed in 
aberrant locations, leading to cocci of uneven size (82) as did mutations in the 
pneumococcal lytR alone (92).  Mutation of the Enterococcus hirae psr gene led to 
increased sensitivity to the cell wall targeting antimicrobial, lysozyme (93).  Together 
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these studies indicate that LCP family members play key roles in stability of the Gram-
positive cell wall and in proper cell division.   
Our data similarly show disruption of the GBS cell wall and cell division in cpsA 
mutant strains or through binding of the CpsA peptide to the wild type strain causing the 
formation of long chains of cocci.  Visualization of FITC-labeled peptide that contains 24 
amino acids from the C-terminal end of the CpsA accessory domain binding to the 
midcell region of the bacteria, potentially at the division septae, is the first time that 
CpsA has been shown to interact physically with the cell division process, though LCP 
family members of S. pneumoniae also have been shown to be localized at the midcell 
septal region (82).  This interaction results in wild type strains forming abnormally long 
chains of cocci.  This phenotype of bacteria forming abnormally long chains of cocci, 
with cell walls of uneven thickness and multiple division septae forming per cell also 
occurs when the accessory domain is expressed in the absence of the LCP domain, 
either through episomal expression of truncated CpsA in the cpsA deletion strain, or in 
the case of the cpsA-insert strain, which has expression of a chromosomal truncated 
CpsA.  These results suggest that either the LCP domain is required for proper function, 
or the accessory domain is participating in aberrant interactions preventing proper 
function of the protein.  This provides an explanation as to why the episomally 
expressed CpsA protein truncations containing all or part of the accessory domain 
(cpsA-245, -210, -187, -153 and -132) cannot complement for capsule expression when 
expressed in the cpsA deletion strain (figure 3).  However, episomal expression of the 
CpsA protein truncation that removes the entire extracellular domain (CpsA-117) is able 
to complement for capsule expression when expressed in the cpsA deletion strain.  
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Collectively, these results demonstrate that the intracellular and transmembrane 
domains alone of CpsA are able to complement the deletion in vitro, but only in the 
absence of the accessory domain. 
The CpsA protein of S. pneumoniae as well as the zoonotic fish pathogen 
Streptococcus iniae has been implicated in regulation of expression of the cps locus 
genes and in virulence (37, 39-41, 45, 47, 81). Proper regulation of cps gene expression 
is also critical for invasive infection by S. pneumoniae.  Ectopic expression of the S. 
pneumoniae cps locus from a constitutively strong or weak promoter caused attenuation 
of colonization and virulence in animal models (44). S. pneumoniae strains that are 
more invasive have higher expression of cpsA in in vitro growth, indicating that cpsA 
has a role in virulence in invasive infections (42).  Similarly, an S. iniae strain with an 
insertion in the cpsA gene had reduced capsule expression and reduced lethality and 
ability to disseminate to major organs in a zebrafish model of systemic disease (81).   
The GBS cpsA-insertion strain analyzed in this work carries a non-polar 
chromosomal insertion in the cpsA gene, resulting in expression of a truncated CpsA 
containing the accessory domain but missing the LCP domain. As was shown for S. 
iniae and S. pneumoniae, GBS CpsA mutants are also attenuated for virulence.  We 
demonstrated that the cpsA-insertion strain produces less capsule than the cpsA 
deletion strain and is further attenuated in human blood and in dissemination to major 
zebrafish organs than the cpsA deletion strain, indicating expression of a truncated 
CpsA is even more detrimental to GBS virulence than the complete absence of CpsA.  
This suggests that the aberrant function of the CpsA accessory domain, either alone or 
in the presence of the wild type CpsA protein, plays an important role in virulence.  This 
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could be at the level of capsule disregulation, or cell wall instability could be causing 
increased bacterial lysis in vivo, or a combination of both.   
While this truncation of the CpsA protein is causing a function that we assume is 
aberrant for the normal full length CpsA, conversely, the accessory domain may have a 
function in vivo of controlling downregulation of capsule production when in particular 
host environments. Specific conformations of the full-length protein may allow the 
accessory domain to interact with CpsA binding partners in a negative way, thereby, 
causing inhibition of capsule production and cell wall synthesis/division.  The recent 
crystal structure of the S. pneumoniae Cps2A revealed a region that could not be 
modeled, containing a disordered loop (35, 82). When comparing this structure to the 
GBS CpsA, we find that the disordered loop region is in the most C-terminal region of 
the accessory domain, the region responsible for the dominant negative effect of the 
CpsA-245 protein. Therefore, this region of the protein may take on multiple 
conformations in response to sensing of the local environment, allowing positive or 
negative interactions with components of the capsule production/cell wall machinery. 
The ability to produce the dominant negative effect from extracellular addition of 
the CpsA peptide has obvious implications for treatment and/or prevention of GBS 
infection. Since GBS treated with the dominant negative factor have less capsule, this 
would allow clearance by the host immune system. Furthermore, these bacteria also 
have aberrant cell walls potentially making them more susceptible to lysis in vivo.  
Research is currently in progress to further exploit and optimize these phenotypes.  
Taken together, this study provides additional information on the roles of the 
extracellular domains of GBS CpsA in capsule expression, cell wall integrity and in 
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virulence of GBS.  This supports a role of LCP family members as serving key functions 
in regulation of cell envelope polysaccharide expression and cell wall integrity and as 




CHAPTER 3: EFFECTS BY LEUCINE ZIPPER MOTIF OF CPSA ON GBS CELL 
ENVELOPE 
Introduction: 
The leucine zipper motif is a common protein-protein interaction domain.  
Leucine zipper motifs are characterized by 5-6 leucines 6 amino acids apart, to allow all 
to be on the same face of an alpha helix.  These motifs participate in homo- or 
heterodimerization of proteins.  Most often this domain stabilizes the interaction of 
transcriptional regulators with their cognate DNA sequences. (94). 
Leucine zipper motifs were first discovered in eukaryotic transcriptional 
regulation, C/EBPα and Fos-Jun being the earliest and best characterized.  Later work 
showed these motifs were also found in bacteria.  The DnaA protein, involved in 
bacterial chromosome origin of replication recognition, forms a homomultimeric protein 
complex aided by protein-protein interactions at an N-terminal leucine zipper motif (95-
97).  Global transcriptional regulatory proteins of bacteria including PrfA of Listeria 
monocytogenes (98), VirB of Shigella flexneri (99), and RegA of Citrobacter rodentium 
(100) are leucine rich and contain putative leucine zipper motifs.  The LacR repressor of 
carbohydrate catabolism genes of Escherichia coli requires tetramerization for full 
function, while radiation induced damage to the leucine zipper motif blocks 
tetramerization (101). 
Leucine zipper motifs have other diverse functions in bacterial proteins. A leucine 
zipper motif is important to stabilize the multimeric complex important for protease 
function in the essential protease FtsH of Escherichia coli (102).  A cell surface and 
secreted protein, Lzp, of Streptococcus pyogenes functions as a virulence factor binding 
 42 
 
human immunoglobulins for immunoevasion by the pathogen (103).  The plant 
pathogen Agrobacterium tumefaciens requires a type IV secretion system for virulence, 
and a leucine zipper motif is key for formation of the required pilus (104).    
Many bacterial cell division proteins contain leucine zipper motifs.  The 
chromosome segregation protein, ParB, of Pseudomonas aeruginosa contains a leucine 
zipper motif important for dimerization and DNA-protein interactions at the parC sites 
and also interaction with its partner ParA for proper nucleoid segregation (105).  These 
motifs are also important for proper assembly of the divisisome complex in E. coli (106, 
107).  In Bacillus subtilis and Staphylococcus aureus a leucine zipper motif in the YlaN 
proteins is important for cell shape (108, 109). 
We identified a leucine zipper motif in the first transmembrane domain of the 
CpsA protein of GBS (figure 11).  A transmembrane localization of a leucine zipper motif 
is not unusual (104, 110, 111).  We demonstrate that this motif is important for CpsA 
functions in capsule production and cell wall integrity.  Episomal expression of CpsA 
protein with a mutation in the leucine zipper motif fails to complement a cpsA deletion 
strain for capsule production and causes a dominant negative effect on capsule 
production when expressed in the wild type strain.  Further, episomal expression of 
leucine zipper mutant CpsA leads to formation of long chains of cocci and cell wall and 
division abnormalities.  Also, purified CpsA protein with the leucine zipper motif mutated 
is less stable in vitro.  In vivo multimerization assays, of tagged wild type and leucine 
zipper mutant CpsA expressed in E. coli, showed that this motif is not necessary for 





Figure 11: Schematic of CpsA showing topology and sequence of first two N-
terminal transmembrane domains: leucine zipper motif in red and larger font, 




Materials and Methods: 
Bacterial strains and growth conditions: 
Leucine zipper mutant cpsA for overexpression in GBS was made using splicing 
by overlap extension PCR to change the three internal leucines (L24, L31, L38) of the 
motif to alanines using primers 5’ MBP-BglII site and 3’ cpsA L to A, and 5’ cpsA L to A 
and 3’ cpsA BglII site (see table 2 for sequences) and using a 1500 bp fragment 
digested with BglII from pGBS-cpsA-full (Hanson, 2012) as a template, then ligated 
back into pGBS-cpsA-full to create pGBS-cpsA-leu zip.  This allowed the protein to be 
expressed as a maltose binding protein (MBP) fusion, allowing for identification using 
anti-MBP antibody in Western Blot analysis.  The construct was expressed in pLZ12-
rofA allowing constitutive expression in GBS. 
Extracellularly truncated leucine zipper mutant cpsA for overexpression in GBS 
was made using pGBS-cpsA-leu zip as template and primers 5’ MBP RBS BamHI and 
3’ GBS cpsA 117-STOP-PstI (see table 2).  It was cloned into the BamHI and PstI sites 
of pLZ12-rofA to allow consititutive expression in GBS. 
Leucine zipper mutant cpsA for MBP purification was made using splicing by 
overlap extension PCR and primers: 5’GBS-cpsA-MBP-Smal and 3’ cpsA Lto A, and 5’ 
cpsA L to A and 3’ GBS cpsA-full-PstI (see table 2 for sequences) and 515 genomic 
DNA as a template.  It was then cloned into the XmaI and PstI sites of pMal-c2x (NEB) 
and purified as described previously (Hanson 2012). 
Leucine zipper mutant cpsA for C-terminal intein-chitin binding protein (CBP) 
purification and detection with anti-CBP antibody via Western Blot was made using 
splicing by overlap extension PCR and primers 5’GBS cpsA intein NdeI and 3’ cpsA L to  
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Table 2: Primers used in chapter 3 
 
5’ MBP-BglII site CAAAGATCTGCTGCCGAACC 
5’ cpsA-L to A GAT TAA TTT ATT TGC TTT GGT GAT TTT TAT 
TTT GGC AAG TGT  
AGT CTC ATT ATT TGC TAT GTA TCG TCA CC 
3’ cpsA-L to A GGT GAC GAT ACA TAG CAA ATA ATG AGA CTA 
CAC TTG CCA AAA TAA AAA  
TCA CCA AAG CAA ATA AAT TAA TC 
3’ cpsA BglII site CAT CAG ATC TTG ATA CTG TTG 




AAA ACT GCA GTT ACT CAA TTT CAG AGT ATC 
AAG C 
5’ GBS-cpsA-MBP-Sma1 TCC CCC GGG TCT AAT CAT TCG CGC CGT C 
3’ GBS-cpsA-Full-Pst1 AAA ACT GCA GTT ATT CCT CCA TTG TGT TC 
5’ GBS cpsA intein NdeI GGA ATT CCA TAT GTC TAA TCA TTC GGC G 
3’ GBS cpsA intein SapI GAG GGC TCT TCC GCA TTC CTC CAT TGT GTT 
C 
5’ RBS intein BamHI CGCGGATCCGAAGGAGATATACATATG 










A, and 5’ cpsA L to A and 3’ GBS cpsA intein SapI (see table 2 for sequences) and 515 
genomic DNA as a template and cloned into the NdeI and SapI sites of pTXB1 (NEB) to 
make pTXB1-cpsA-leu zip. Wild type cpsA for C-terminal intein purification was made 
using primers 5’ GBS cpsA intein NdeI and 3’ GBS cpsA intein PstI (see table 2 for 
sequences) and 515 genomic DNA as a template and cloned into the NdeI and SapI 
sites of pTXB1 to make pTXB1-cpsA.  CpsA-intein-CBP fusion proteins for over 
expression in GBS were made using primers 5’ RBS intein BamHI and 3’ intein PstI 
(see table 2 for sequences) and the pTXB1-cpsA and pTXB1-cpsA-leu zip plasmids as 
templates, and cloned into the BamHI and PstI sites of pLZ12 to make pGBS-cpsA-
intein and pGBS-cpsA-leu zip-intein respectively. 
C terminally FLAG tagged CpsA for FLAG purification and detection with anti-
FLAG antibody via Western Blot was made using primers 5’GBS cpsA RBS BamHI and 
3’ GBS cpsA FLAG PstI using 515 genomic DNA as template.  Leucine zipper mutant 
CpsA with C-terminal FLAG tag was made using splicing by overlap extension PCR and 
primers 5’GBS cpsA RBS BamHI and 3’ cpsA L to A, and 5’ cpsA L to A and 3’ GBS 
cpsA FLAG PstI (see table 2 for sequences) and 515 genomic DNA as template. 
Digested PCR products were cloned into the BamHI and PstI sites of pLZ12 rofA to 
make pGBS cpsA FLAG and pGBS cpsA leu zip-FLAG respectively. 
Percoll buoyant density centrifugation: 
Buoyant density was determined using linear Percoll (GE Healthcare) gradients.  
Percoll solutions of low (1.085 g/mL) and high density (1.120 g/mL) were made and 
supplemented with a final concentration of 0.15mM NaCl.  2 mL low-density solution 
was carefully overlaid onto 2 mL high-density solution in a 5 mL Falcon tube (BD).  
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Tubes were placed at a 15-degree angle and allowed to form continuous gradients 
overnight.  Tubes were placed vertically 30 minutes prior to assay to allow gradients to 
settle.  Bacterial cultures were grown in Todd Hewitt (Alpha Biosciences) + 0.2% yeast 
extract (Acumedia) supplemented with appropriate selective antibiotics.  Overnight 
cultures were normalized to OD600=0.6 per 1 mL and concentrated to 50µL in phosphate 
buffered saline.  Culture was carefully added to top of gradient and centrifuged 30 
minutes at room temperature and 5000 rpms in a swinging bucket centrifuge (Eppendorf 
Centrifuge 5403 with Rotor 16A4-44).  Distance of migration was measured from the 
bottom of the meniscus and density calculated from the distance of migration of beads 
of known density.  
Microscopy: 
Phase contrast microscopy was performed on overnight cultures of bacteria 
grown in Todd Hewitt (Alpha Biosciences) supplemented with 0.2% yeast extract 
(Acumedia) supplemented with appropriate selective antibiotics.  Wet mounts were 
made of 3 mL culture and were photographed (Zeiss Axioscope 40 and imaged with 
Axiovision 4.7).  Images are of representative fields of at least 3 biological replicates.   
Fluorescent vancomycin staining was performed on midlog cultures.  Bacteria 
were grown overnight and then subcultured 1:50 in Todd Hewitt (Alpha Biosciences) 
supplemented with 0.2% yeast extract (Acumedia) with appropriate selective antibiotics.  
At midlog (OD600=0.3) cultures were concentrated to OD600=1.0.  10µL culture and a 
final concentration of 1µg/µL BODIPY_FL vancomycin (Life Technologies) were 
incubated 10 minutes at 37 degrees to allow incorporation of stain into newly formed 
cell wall.  Cultures were then washed 3 times in phosphate buffered saline and then 
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were resuspended in 3µL phosphate buffered saline and observed as a wet mount 
(Zeiss Axioscope 40 using a FITC filter and imaged with Axiovision 4.7).  Images are of 
representative fields from 3 biological replicates. 
SDS-PAGE analysis: 
In vitro protein stability was determined by SDS-PAGE analysis.  Equal amounts 
of CpsA-full-MBP (38)and CpsA-leu zip-MBP were mixed with 6X SDS loading buffer 
and boiled 15 minutes prior to loading a 12% SDS-PAGE gel.  Samples were run at 83V 
through the stacking gel and voltage increased to 96V for resolving.  Dye front was run 
off the bottom of the gel and stained using the Simply Blue Safe Stain (Invitrogen). 
Multimerization analysis: 
In vitro multimerization was performed with purified MBP-cpsA full.  5µg protein 
was mixed with 0-1% formaldehyde for 10 minutes at room temperature.  Crosslinker 
was quenched with 0.8 mM glycine and 6X SDS buffer was added.  Samples were 
boiled 5 minutes and separated on a 12% SDS-PAGE gel, and stained using Simply-
Blue Safe stain. 
In vivo multimerization analysis were performed on E. coli cultures expressing 
pMal-cpsA constructs.  Overnight cultures were diluted 1:100 in fresh media and grown 
3 hours.  They were then induced 2 hours with 0.3 mM IPTG.  Cultures were normalized 
to OD600=1.0 and washed three times in Phosphate Buffered Saline (PBS).  Samples 
were crosslinked 30 minutes at room temperature with 2 mM DSP (Thermo Fisher).  
Crosslinker was quenched by resuspending sample in 20mM Tris, 20% Sucrose, 1mM 
EDTA buffer supplemented with HALT Protease inhibitor cocktail (Thermo Fisher).  
Samples were sonicated in a bath sonicator for 5 minutes of 10 second on/ 10 second 
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off pulses.  Control (non crosslinked) and samples for crosslink reversal were mixed 
with 6x SDS sample buffer and crosslinked samples were mixed with 6x non-reducing 
SDS sample buffer and boiled 5 minutes.  Samples were separated on a 6% SDS-
PAGE gel, transferred to a PVDF membrane (SantaCruz), blocked with 4% milk in 
TBST buffer.  Anti-MBP polyclonal serum was diluted 1:10,000 in blocking buffer and 
membrane incubated overnight at 4°C overnight with agitation.  Primary antibody was 
washed off with three washes in TBST and goat-anti-rabbit conjugated to Alkaline 
Phosphatase was incubated for 3 hours at room temperature with agitation.  Secondary 
antibody was washed off with three washes in TBST.  The membrane was equilibrated 
5 minutes in detection buffer, and then detected with BCIP at 0.1 µg/mL in detection 
buffer with agitation until bands developed. 
Virulence Assays: 
Zebrafish infections were performed by injecting fish intramuscularly with 106 cfu of 
midlog bacteria.  Four hours post injection fish were sacrificed and spleens, hearts, and 
brains were isolated.  Organs were homogenized and plated on CNA agar plates 
(Acumedia) supplemented with chloramphenicol to ensure that cfu count reflected 
bacteria that had maintained the plasmid during infection.   
Results: 
A leucine zipper motif was identified in CpsA, within the first transmembrane 
domain (figure 11).  The three internal leucines of this motif were mutated to alanines 





Capsule expression by leucine zipper mutant CpsA:  
Deletion of cpsA leads to a reduction in capsule gene expression by RT-PCR 
and in capsule levels by ELISA (48) and buoyant density centrifugation (38). To 
determine the role of the leucine zipper motif in CpsA function, we expressed a leucine 
zipper mutant CpsA ectopically, utilizing the pGBS-cpsA-leu zip plasmid in wild type and 
ΔcpsA bacteria and performed buoyant density centrifugation (Figure 12).  Capsule 
levels of wild type bacteria episomally expressing the leucine zipper mutant CpsA were 
significantly reduced compared to wild type bacteria with empty vector alone, indicating 
the leucine zipper mutant protein is exerting a dominant negative effect.  Capsule levels 
of ΔcpsA bacteria episomally expressing the leucine zipper mutant CpsA were 
comparable to the ΔcpsA strain with empty vector, while capsule levels of ΔcpsA 
bacteria episomally expressing wild type CpsA were restored to wild type levels.  This 
indicates that episomal expression of the leucine zipper mutant CpsA fails to 
complement the cpsA deletion, whereas episomal expression of the wild type CpsA 
does. This suggests that the leucine zipper domain plays a role in activation of capsule 
production.  Additionally, since episomal expression of the leucine zipper mutant CpsA 
causes a decrease in capsule levels of wild type bacteria, this suggests that the leucine 
zipper motif is facilitating key protein-protein interactions of CpsA essential for capsule 
production.  
Capsule production by extracellularly truncated leucine zipper mutant CpsA: 
Truncation of the extracellular domain of the CpsA protein showed this region is 
key for protein function.  An episomally expressed truncated CpsA missing the entire 





Figure 12: Capsule production with episomal expression of leucine zipper mutant 
CpsA. Percoll buoyant density centrifugation, ns=not significant, *p<0.05, **p<0.01  
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whereas an episomally expressed truncated CpsA missing the most C terminal domain 
(the LCP domain) is unable to complement the cpsA deletion, and further, has a 
dominant negative effect when expressed in the wild type strain ((38), Chapter 2).  
Therefore we examined the effects of the leucine zipper motif in the absence of the 
extracellular domain and constructed an episomal CpsA-117 leucine zipper mutant.  
This mutant, when expressed in wild type, has a dominant negative effect on capsule 
production, whereas the episomally expressed wild type CpsA-117, in a wild type strain, 
has wild type capsule levels.  Further, the leucine zipper mutant CpsA-117 cannot 
complement the cpsA deletion, while the wild type CpsA-117 is capable of 
complementing the deletion  (Figure 13). This shows that the leucine zipper motif is 
important for the function of the CpsA protein, even in the absence of the extracellular 
domain. 
Cell wall phenotypes from episomal expression of leucine zipper mutant CpsA: 
Deletion of cpsA leads to a long chain phenotype in GBS, as does episomal 
expression of a truncated form of CpsA missing the C terminal LCP domain (38). This 
long chain phenotype is indicative of cell wall abnormalities when CpsA is not present or 
is non-functional, as in the ΔLCP form of CpsA.  To determine the effects of the leucine 
zipper motif on chain length we observed overnight cultures under phase contrast 
microscopy (Figure 14A).  Wild type bacteria expressing the leucine zipper mutant CpsA 
protein formed longer chains than wild type harboring empty vector alone.  Additionally, 
the cocci were larger and the chains appeared to be kinked.  This indicates that in 
addition to the dominant negative effect on capsule production (Figure 14) the leucine 




Figure 13: Capsule production with episomally expressed leucine zipper mutant 





Figure 14: Phase contrast microscopy of episomally expressed leucine zipper 
mutant CpsA. A) WT/vector, B) ΔcpsA/vector, C) WT/pCpsA-leuzip, D) ΔcpsA/pCpsA-
leuzip.  All at 1000x magnification.   
 55 
 
bacteria episomally expressing leucine zipper mutant CpsA formed chains of similar 
length to ΔcpsA with empty vector, indicating that the leucine zipper mutant CpsA fails 
to complement the deletion, as in capsule levels. Furthermore, the chains of the ΔcpsA 
bacteria episomally expressing leucine zipper mutant CpsA appeared kinked and had 
larger cocci.  This indicates the cell wall deficits are worse than a mere deletion of cpsA. 
To further examine possible cell wall defects, we performed fluorescent vancomycin 
staining (Figure 15).  The antibacterial action of vancomycin is through the blocking of 
crosslinking of cell wall muropeptide subunits.  Fluorescent vancomycin will therefore 
label newly formed cell wall by labeling only non-crosslinked muropeptide subunits.  
This allows visualization of the septae as this is where most cell wall is formed.  Wild 
type bacteria (Figure 15A) with empty vector exhibit an even ring of cell wall around 
each coccus and a single bright pole per coccus, indicating the forming division septa.  
Episomal expression of the leucine zipper mutant CpsA (Figure 15C) in the wild type 
background leads to uneven cell wall thickness around each coccus and no clear pole 
indicating a forming division spetae.  Also, as in the phase contrast images, the chains 
appear kinked.  ΔcpsA strain (Figure 15B) with empty vector formed long chains.  Cell 
wall staining is less even around each coccus than in wild type, exhibiting thick staining 
at the septa, possibly indicating incomplete separation of cocci following division.  All 
septae are located in the same plane, giving the chains a straight phenotype.  ΔcpsA 
strain episomally expressing a leucine zipper mutant CpsA (Figure 15D) has uneven 
cell wall staining around each coccus.  Some cocci exhibit multiple bright poles, 
indicating multiple septation events per cell.  Furthermore these septae are not in the 





Figure 15: Fluorescent vancomycin staining of episomally expressed leucine 
zipper mutant CpsA. A) WT/vector, B) ΔcpsA/vector, C) WT/pCpsA-leuzip, D) 
ΔcpsA/pCpsA-leuzip.  Scale bar indicates 10µm.   
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suggest that CpsA is important for cell wall maintenance and cell division, and that the 
leucine zipper motif is important in these processes.   
Stability of purified CpsA: 
Since leucine zipper motifs are important for protein-DNA interactions and GBS 
CpsA is a DNA binding protein (38) we purified the leucine zipper mutant CpsA as an 
MBP fusion protein to examine the role of this motif in CpsA promoter binding.  SDS- 
PAGE analysis of purified protein (Figure 16) indicated that this protein is not stable in 
vitro.   Purified protein of the wild type sequence is primarily the expected 96 kDa fusion 
protein.  However, the purified leucine zipper mutant protein is primarily the 43 kDa 
MBP alone degradation product, indicating that the mutation of the leucine zipper motif 
has made this protein unstable. 
Multimerization of CpsA: 
Leucine zipper motifs are also important for protein multimerization, therefore we 
examined the ability of CpsA and leucine zipper mutant CpsA to multimerize.  The first 
experiment examined in vitro crosslinking using formaldehyde (figure 17).  When adding 
formaldehyde to purified wild type protein, three multimers were visualized.  Since the 
leucine zipper mutant purified protein was unstable and CpsA is a membrane protein, 
and membrane localization might be important to proper protein function, we examined 
multimerization of MBP fusion proteins expressed in E. coli (Figure 18).  Both wild type 
and the leucine zipper mutant CpsA proteins when uncrosslinked are primarily the 
expected 96 kDa fusion protein, therefore in vivo we do not observe the protein stability 
issues that occurred with the purified protein in vitro.  Reversing the crosslink restores 





Figure 16: SDS-PAGE analysis of purified MBP-tagged wild type (WT) and leucine 
zipper mutant (LZ) CpsA.  Indicated amount of purified protein was analyzed by SDS-




Figure 17: Formaldehyde crosslinking of purified MBP-tagged wild type CpsA. 
Purified protein was incubated with indicated concentration of formaldyhyde and then 






Figure 18: in vivo crosslinking of E. coli lysates expressing MBP-tagged wild type 
CpsA (full) or leucine zipper mutant CpsA (LZ). Protein expression was induced and 
then lysates were crosslinked by DSP, followed by sonication and Western Blot analysis 
to determine mulitmerization.  
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not contain clear bands indicating multimerization of either wild type or leucine zipper 
mutant CpsA.  Therefore at this time we are unable to determine the role of the leucine 
zipper motif in multimerization of CpsA. 
Since the extracellular domain of CpsA is also important for CpsA function ((38) 
and Chapter 2) and could potentially be participating in homomultimerization, we next 
examined the multimerization of the CpsA-117 and CpsA-leucine zipper mutant-117 in 
E. coli to determine the importance of the leucine zipper motif in multimerization in the  
absence of the extracellular domain (Figure 19).  Both wild type CpsA-117 and leucine 
zipper mutant CpsA-117 are similarly stable in vivo in the no crosslink control samples, 
with the primary species being the expected 53 kDa fusion protein.  Reversing the 
crosslink does not restore the same species as the uncrosslinked control indicating that 
there is an aggregation event unrelated to our crosslinking, so at this time we cannot 
determine the role of the leucine zipper motif in multimerization of extracellularly 
truncated CpsA. 
C-terminally tagged CpsA: 
In order to examine CpsA multimerization further and the role of the leucine 
zipper mutant in that multimerization other tagged versions of CpsA were generated.  N-
terminal MBP-tagged CpsA was never able to be shown to be expressed in GBS by 
western blot (data not shown).  The possibility that N-terminal modifications were 
occurring led us to make C-terminal fusions.  Additionally, having multiple tags available 
would allow for multiple options in coimmunoprecipitaion studies.  A C-terminal intein-
chitin binding protein construct was produced.  This construct, when expressed in GBS, 





Figure 19: in vivo crosslinking of E. coli lysates expressing MBP-tagged wild type 
CpsA-117 (WT) or leucine zipper mutant CpsA-117 (LZ). Protein expression was 
induced and then lysates were crosslinked by DSP, followed by sonication and Western 






Figure 20: Capsule production by episomally expressed C-terminal intein-tagged 





Figure 21: Capsule production by episomally expressed C-terminal FLAG-tagged 
CpsA and leucine zipper mutant CpsA. Percoll buoyant density centrifugation.  
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This could be due to the large C-terminal tag inhibiting the proper function of the 
extracellular domains.  
C-terminally FLAG-tagged CpsA and leucine zipper mutant CpsA were also 
constructed. A FLAG-tagged wild type CpsA episomally expressed in the cpsA deletion 
strain was able to complement capsule production (Figure 21), indicating that the small 
C-terminal FLAG tag does not interfere with protein function.   The FLAG-tagged leucine 
zipper mutant CpsA had a similar phenotype to the N-terminally MBP-tagged leucine 
zipper mutant CpsA in that it cannot complement the cpsA deletion strain for capsule  
production and has a dominant negative effect on capsule production when expressed 
in the wild type strain. 
Virulence effects of episomally expressed leucine zipper mutant CpsA: 
To examine virulence consequences of the leucine zipper motif, zebrafish were 
infected with the wild type and cpsA deletion strains with empty vector or expressing 
pGBS-cpsA-leu zip, and bacterial dissemination to spleens, hearts and brains was 
determined by plating for viable cfu four hours post infection (Figure 22).  The cpsA 
deletion strain was attenuated in all three organs, and the cpsA deletion strain 
episomally expressing pGBS-cpsA-leu zip could not complement the deletion for 
dissemination to the spleen.  The wild type strain, episomally expressing pGBS-cpsA-
leu zip exhibited similar dissemination to the wild type strain with empty vector.  This 
indicates that at least at early time points post infection, episomal expression of leucine 
zipper mutant CpsA in a wild type strain does not have a dominant negative effect on 
virulence.  Episomal expression of a leucine zipper mutant cpsA in a cpsA deletion 





Figure 22: GBS dissemination to zebrafish major organs. 4 hpi cfu/organ following 
106 cfu per fish intramuscular injection.  Each point represents one fish, bar is mean. 





at least at early time points post infection.  Further analysis with a chromosomal leucine 
zipper mutant will be necessary to examine later time points post infection such that 
plasmid loss is not a factor.  
Discussion: 
 The leucine zipper motif located in the first transmembrane domain of the CpsA 
protein is important for both the capsule expression and cell wall integrity/cell division 
functions of CpsA.  Expression of a protein with the three internal leucines of this motif 
mutated to alanines is unable to complement a cpsA deletion strain for capsule 
production or cell wall integrity.  Additionally, this mutant protein, when expressed 
episomally in the wild type strain, causes a dominant negative effect on both capsule 
expression and cell wall integrity.  This suggests that the leucine zipper motif is 
mediating key interaction between CpsA and itself, as we have seen 
homomultimerization of wild type CpsA, and/or with its binding partners. 
 Further work needs to be done to see if the leucine zipper motif is acting to cause 
specific binding of DNA at the cpsA promoter.  This will require purification of a stable 
leucine zipper mutant CpsA protein to perform electrophoretic mobility shift assays 
(EMSAs).  If the FLAG-tagged leucine zipper mutant CpsA is also found to be unstable 
in vitro, purified membrane fraction containing CpsA or leucine zipper mutant CpsA 
could be used in EMSAs.   
Also, further work on the multimerization of CpsA needs to be done.  Better 
cross-linking in vivo, either in E. coli or ideally in GBS lysates, needs to be performed to 
see clear multimers of CpsA and determine the role of the leucine zipper motif.  
Additionally the binding partners of CpsA need to be determined.  Co-
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immunoprecipitation of both full length and CpsA-117 with and without the leucine 
zipper motif will identify the binding partners of CpsA that bind the extracellular domain 
(interact with CpsA full, and CpsA-leu zip-full, but not the CpsA-117 truncations) and 
that bind the leucine zipper motif (those that interact with CpsA full and CpsA-117, but 
not the leucine zipper mutants).  Additionally, binding partners that interact at the 
leucine zipper motif could be predicted by bioinformatics identifying transmembrane 




CHAPTER 4: ROLE OF LYTR IN CELL ENVELOPE MAINTAINENCE OF GBS 
 
Introduction: 
The LytR-CpsA-Psr (LCP) family of proteins is a widespread class of proteins 
from many Gram-positive bacterial species (34, 35).  These proteins are involved in cell 
envelope regulation and stability.  Recently, they have been implicated in the 
attachment of cell wall sugars, capsule and wall teichoic acids, to the peptidoglycan cell 
wall (35, 82, 83).   
LytR is a transcriptional regulator of autolysin production in many Gram-positive 
species of bacteria(35, 92, 112-114).  Addionally it has been implicated in the proper 
formation of division spetae in Streptococcus pneumoniae (92). 
In many species of Gram-positive bacteria LCP family members have been 
shown to compensate for each other and disruption of multiple LCP proteins has been 
shown to lead to severe bacterial growth and survival deficits.  In Staphylococcus 
aureus triple deletion of all three LCP proteins leads to bacteria without wall teichoic 
acids, instead releasing teichoic acid into the culture supernatant (115).  Streptococcus 
pneumoniae double LCP mutants release capsule into the culture supernatant (82).  
Multiple deletion of LCP genes can be lethal in Streptococcus mutans (85) or cause 
severe growth deficits in the absence of compensatory gene mutations (35, 82, 86, 
116).   
In this work, we characterize an insertional mutantion disrupting the lytR gene of 
GBS.  We disrupt lytR in both a wild type and cpsA deletion background to determine 
the effects of lytR individually and in combination with cpsA in bacterial growth, capsule 




Materials and Methods: 
Construction of LytR::pUC insert mutants: 
The LytR insert was constructed by amplifying a 490 bp region from 515 genomic 
DNA using primers (5’ GBS LytR ins EcoRI- 
CCGGAATTCGCTAAATCATCATGAAGAGC- and 3’ GBS LytR ins PstI- 
AAAACTGCAGTTAAGCTCCCATCAACAGC) and cloned into the EcoRI and PstI sites 
of plasmid pUC19-Erm (45).  Plasmid was electrotransformed as described previously 
(38) into GBS strain 515 and its isogenic cpsA deletion strain (48), single crossover 
recombinants were selected by resistance to Erythromycin on THY (Todd Hewitt 
(Acumedia) supplemented with 0.2% yeast extract (Acumedia) and 1.4% bacteriological 
agar (Acumedia)) Erm 2 µg/mL plates. 
Bacterial growth curves: 
Growth curves were done by normalizing overnight bacterial cultures to an 
OD600=1.0 and then diluted 1:50 in fresh THY (Todd Hewitt (Alpha Biosciences) 
supplemented with 0.2% yeast extract (Acumedia)), and 200 µL of culture was put into a 
96 well plate in triplicate and OD600 read every hour for 7 hours.  Data is representative 
of three biological replicates. 
Percoll gradient buoyant density analysis: 
Buoyant density was determined using linear Percoll (GE Healthcare) gradients.  
Percoll solutions of low (1.085 g/mL) and high density (1.120 g/mL) were made and 
supplemented with a final concentration of 0.15mM NaCl.  2 mL low-density solution 
was carefully overlaid onto 2 mL high-density solution in a 5 mL Falcon tube (BD).  
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Tubes were placed at a 15-degree angle and allowed to form continuous gradients 
overnight.  Tubes were placed vertically 30 minutes prior to assay to allow gradients to 
settle.  Bacterial cultures were grown in Todd Hewitt (Alpha Biosciences) + 0.2% yeast 
extract (Acumedia).  Overnight cultures were normalized to OD600=0.6 per 1 mL and 
concentrated to 50µL in phosphate buffered saline (PBS).  Culture was carefully added 
to top of gradient and centrifuged 30 minutes at room temperature and 5000 rpms in a 
swinging bucket centrifuge (Eppendorf Centrifuge 5403 with Rotor 16A4-44).  Distance 
of migration was measured from the bottom of the meniscus and density calculated 
from the distance of migration of beads of known density (GE Healthcare).  Data is 
average of four biological replicates.  
Microscopy: 
Phase contrast images were performed on overnight cultures grown in THY.  5µL 
of culture was placed on a microscope slide and mounted with a cover slip and 
visualized on a Zeiss Axioscope 40 and imaged with Axiovision 4.7.  Images are of 
representative fields of at least 3 biological replicates.   
Fluorescent vancomycin staining was performed on midlog cultures.  Bacteria 
were grown overnight and then subcultured 1:50 in THY.  At midlog (OD600=0.3) 
cultures were concentrated to OD600=1.0.  10µL culture and a final concentration of 
1µg/µL BODIPY_FL vancomycin (Life Technologies) were incubated 10 minutes at 37 
degrees to allow incorporation of stain into newly formed cell wall.  Cultures were then 
washed 3 times in PBS and then were resuspended in 3µL PBS and observed as a wet 
mount (Zeiss Axioscope 40 using a FITC filter and imaged with Axiovision 4.7).  Images 




Human whole blood infections were performed.  Overnight bacterial cultures 
were diluted 1:50 in fresh THY and grown to midlog.  At midlog, cultures were 
normalized to an OD600 =0.3, corresponding to 108 cfu/mL. Normalized cultures were 
resuspended in PBS, then diluted 1:10 in PBS.  A 20µL inoculum (2x105 cfu) per 1 mL 
blood, in triplicate, was incubated 3 hours at 37°C with end over end rotation in 1.7 mL 
tubes (Dot Scientific).  One hundred microliters was plated in duplicate per infection on 
THY agar and viable cfu enumerated.  Log killed was determined by subtracting the log 
of the product cfu from the log of the inoculum cfu. 
Murine macrophage infections were performed.  RAW 267.4 murine 
macrophages were seeded at 106 cells per well of a 24 well plate and allowed to adhere 
overnight.  Bacterial cultures were grown to midlog and normalized to OD600=0.3 =108 
cfu/mL and diluted 1:100 in DMEM +10% fetal calf serum.  Macrophages were washed 
three times in PBS, then infected for one hour.  Non-adherent bacteria were removed 
with five washes in PBS.  Extracellular bacteria were killed with 100µg/mL genatmycin 
in DMEM +10% FCS for one hour.  Antibiotic was washed off with three PBS washes.  
One set of wells was lysed in 1 mL ddH2O and plated for viable count at time =0.  At 18 
and 24 hours post infection the supernatant was removed to enumerate those bacteria 
that had emerged from the macrophages and cells were washed 5 times with PBS then 





Capsule production by LytR-insert mutants: 
The CpsA protein has a role in expression of capsule by GBS.  Deletion of the 
cpsA gene or expression of a truncated CpsA protein leads to decreased capsule 
production (Chapter 2 and (38, 48)).  We first examined the capsule production of the 
lytR::pUC mutant strain and the ΔcpsA lytR::pUC double mutant strain to determine the 
role of the LytR protein alone and in combination with the CpsA protein in capsule 
expression (Figure 23).  Both single mutant strains exhibited a reduction in capsule 
expression compared to the wild type strain, but the strain with a double mutation had 
capsule levels further reduced beyond that of each of the single mutant strains.  This 
indicates that the two proteins can partially compensate for each other to allow some 
capsule production, but in the absence of both proteins, capsule production is greatly 
reduced. 
Growth effects of LytR mutation: 
Since other organisms with multiple mutations in genes encoding LCP proteins  
have growth phenotypes (35, 82, 86, 116), we next examined the growth rates of the 
wild type strain, compared to the  ΔcpsA, lytR::pUC, and ΔcpsA lytR::pUC double 
mutant strains (Figure 24).  The wild type strain and the single mutant strains exhibited 
similar growth kinetics, whereas the double mutant strain exhibited a longer lag phase 
and slower growth rate in log phase.  This could indicate that the disruption of two LCP 






Figure 23: Capsule production by LytR::pUC strains. Percoll buoyant density 
centrifugation. **p<0.01 compared to wild type, ##p<0.01 compared to single (ΔcpsA or 












Figure 25: Phase contrast microscopy. A) wild type, B) ΔcpsA, C) lytR::pUC, D) 
ΔcpsA lytR::pUC. All at 1000x magnification.  
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Cell wall effects of LytR mutation: 
Examination of the lytR::pUC strain under phase contrast microscopy showed the 
bacteria form unusually long chains of cocci (Figure 25).  Wild type bacteria (Figure 
25A) form typical chains of 2-5 cocci in length. The chains of the strains with a single 
mutation (Figure 25B and 25C) were unusually long, and the double mutant strain 
(Figure 25D) formed chains even longer than those of the single mutant strain.  This 
again indicates a combinational effect of LytR and CpsA in bacterial growth since chain 
length irregularities can indicate cell division and cell wall defects.   
Cell wall was further examined by fluorescent vancomycin staining (Figure 26).  
This compound will label newly formed cell wall.  Wild type bacteria (Figure 26A) and 
the cpsA deletion (Figure 26B) bacteria exhibit clear rings of cell wall and even coccus 
size per chain.  Examination of the lytR::pUC (Figure 26C) and the double mutant, 
ΔcpsA lytR::pUC (Figure 26D) strains indicated very aberrant cell walls with cocci of 
uneven size and indications of multiple division septae forming per coccus. 
Virulence effects of LytR mutation: 
The virulence phenotype of the LytR-insert mutant strains was examined by ex 
vivo human whole blood infections. The wild type, ΔcpsA, and lytR::pUC strains were 
killed similarly in human whole blood, whereas the double mutant strain exhibited killing 
greater than one log more than that exhibited by the wild type bacteria (Figure 27).  This 
indicates that the LytR and CpsA proteins can compensate for each other to promote 
survival in blood but loss of both proteins leads to an inability to cause septic infection.   
Since capsule is an antiphagocytic molecule, the ability of these mutant strains to 





Figure 26: Fluorescent vancomycin staining. A) wild type, B) ΔcpsA, C) lytR::pUC, 






Figure 27: Human whole blood bactericidal assay. Log bacteria killed in three hours 
in freshly isolated heparinized human whole blood.  Trend representative of three 
independent experiments. Error bars are standard deviation of three technical 





Figure 28: Murine macrophage infection. Average cfu per well at indicated time point 





double mutant strains were more highly internalized at the zero time point, which is to 
be expected since they are known to be expressing less of an antiphagocytic molecule.  
After 18 and 24 hours the mutant strains have replicated to a higher concentration 
within the macrophages indicating that strains carrying these mutations are more able to 
survive within the macrophages.  Further analysis needs to be done to determine the 
mechanism for this phenotype.  One possibility is that the mutant strains may be less 
able to activate the macrophages and are therefore better able to survive intracellularly.  
To address this possibility, analysis of infection with pre-activated macrophages should 
be performed. Additionally, the mutant strains may not be able to escape the 
macrophages and therefore are reproducing to a higher number intracellularly.  Though 
we do have extracellular counts at 18 and 24 hours showing similar extracellular colony 
forming units (CFUs), those reflect extended growth in rich media.  Therefore 
extracellular CFUs at earlier time points post infection should be determined.  Lastly, the 
mutant strains may not be able to kill the macrophages to the same extent as the wild 
type strain, allowing for better survival within the macrophages.  To examine this effect,  
measurement of  lactate dehydrogenase release from the macrophages, indicating 
membrane damage, could be performed, as well as measuring levels of apoptosis of 
the macrophages. 
Discussion: 
Taken together, the capsule, cell wall and virulence data suggest that the GBS 
CpsA and LytR proteins can partially compensate for each other functionally.  However, 
in the absence of both proteins the bacteria are less able to produce capsule, are less 
able to grow in culture and to survive in human blood, indicating an inability to cause 
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septic infection.  Further virulence assays using a whole animal model, in our case 
zebrafish, should be performed to determine the role of the LytR protein alone and in 
combination with the CpsA protein in their ability to cause lethal infection and ability to 
promote bacterial dissemination to major organs.   
This work is still preliminary, but there are several interesting avenues to pursue.  
Both the CpsA and LytR proteins contain the conserved LCP domain. If this domain is 
the functional enzymatic part of the protein it would be interesting to see how the CpsA 
protein truncations perform in the lytR::pUC and ΔcpsA lytR::pUC strain backgrounds.  
An unexplained finding from our work with the strain expressing the CpsA-117 
truncation is that episomal expression of this protein, which has the entire extracellular 
domain of CpsA removed, is able to complement the cpsA deletion strain for capsule 
expression, but it is unclear by what mechanism.  Perhaps the LCP domain of the LytR 
protein is capable of functionally compensating for the missing LCP domain of the 
CpsA-117 protein truncation.  Additionally, we were unable to explain the mechanism of 
the dominant negative effect of episomal expression of CpsA truncations containing all 
or part of the accessory domain in the absence of the LCP domain.  Expression of these 
truncations in the lytR::pUC and ΔcpsA lytR::pUC strains could further elucidate this 
mechanism since there would not be the confounding LCP domain of the LytR protein 
present.   
The synthetic CpsA peptide should also be examined with the lytR::pUC and 
ΔcpsA lytR::pUC strains.  This could determine if the synthetic peptide is interacting with 
a common substrate/binding partner of both of the LytR and CpsA proteins or if it is 
interacting with a unique substrate/binding partner of CpsA.  If found to have 
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promiscuous activity against multiple LCP family members of the same species, this 
peptide could even have therapeutic implications against multiple Gram-positive 
bacterial pathogens. 
Lastly, a strain with a triple mutation in the genes encoding all three LCP family 
members of S. agalactiae should be produced.   This could further delineate the 
contributions of each member of the LCP family in GBS and give insight into its cell 




CHAPTER 5: VIRULENCE SIGNALING OF THE STREPTOCOCCUS PYOGENES 
SALIVARICIN LOCUS 
Introduction: 
Previous work in our lab identified a highly conserved genetic locus in Streptococcus 
pyogenes as being important for causing systemic disease (52, 53).  This locus had 
homology to the Salivaricin producing locus of the oral commensal bacteria 
Streptococcus salivarius (54). In S. salivarius the gene products of this locus are 
responsible for the production of a lantibiotic peptide, Salivaricin A (55). Salivaricin A 
acts as a pore-forming toxin against many species of Gram-positive bacteria also found 
in the oral microenvironment. (59-61).  Only the M4 serotype of S. pyogenes is capable 
of producing an active lantibiotic from this locus (54, 60), yet all sequenced strains of S. 
pyogenes maintain this locus. This suggests that the gene products of this locus have 
been repurposed in S. pyogenes for a role other than bacteriocin production.  Our data 
showing that mutants in this locus are attenuated in virulence suggests that the role of 
the salivaricin locus in S. pyogenes is in virulence (52, 53). 
The sal locus of S. pyogenes (Figure 29) is bracketed by genes encoding two 
peptides, SalA and SalZ, and contains genes encoding a two-component signaling 
system, SalKR.  Transcription in this locus is from two promoters, one upstream of salA 
and one upstream of salKR. (52).  Differential transcription from the salKR promoter is 
observed when deletions are made in the salA and salKR genes, indicating a role for 




Figure 29: Genomic organization of the S. pyogenes sal locus. White arrows 
indicated open reading frames (ORFs) interrupted by premature stop codons, Grey 
arrows indicate intact ORFs. Small arrows above indicate promotors.  
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The work described here details an examination of the in vitro conditions required 
for specific DNA binding of the SalR protein to the salKR promoter and the roles of the 
peptides, SalA and SalZ, in virulence and transcription of the locus. 
Materials and Methods: 
Bacterial strains, media, and growth conditions: 
Plasmids were maintained in either Escherichia coli DH5α cells or E. coli TOP10 
cells (Invitrogen) and cultured aerobically in Luria-Bertani medium (Acumedia) 
supplemented with 100µg/mL ampicillin (Amp), 25 µg/ml kanamycin (Kan) or 20 µg/mL 
chloramphenicol (Cam) at 37°C. Streptococcus pyogenes strain HSC5 (117-119) and 
isogenic salA, salKR, and salA-salKR deletions (52) were cultured anaerobically in 
Todd-Hewitt medium (Alpha Biosciences) supplemented with 0.2% yeast extract 
(Acumedia) (THY).  When appropriate, S. pyogenes cultures were supplemented with 
selective antibiotics, Cam (3 µg/mL), or Kan (500 µg/mL).  For solid media, THY was 
supplemented with 1.4% bacteriological agar. 
Construction of SalZ insert strain: 
To examine the role of SalZ in virulence and transcription a strain with an 
insertion mutation in the salZ gene was generated. This plasmid insert upstream of the 
salZ gene inserted transcriptional terminators preventing the transcription of salZ. Using 
primers 5’-SalZ-insert-AatII—CAGCGACGTCGAAAATGGTAAGGAGATAGC and 3’-
SalZ-insert-PstI--AAA ACT GCA GCA TAT CAG GCA TTT CCC TAC, a 700 bp 
fragment was amplified from HSC5 genomic DNA and cloned into the AatII and PstI 
sites of pBRΩKM2. The plasmid was electrotransformed into wild type S. pyogenes as 
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described previously (117) and single crossover recombinants were selected by plating 
on THY-Kan agar plates. 
Electrophoretic mobility shift assay (EMSA): 
The SalR protein was purified as an MBP fusion protein using the pMal-c2x 
system (NEB).  Using primers 5-SalR-SmaI—
TCCCCCGGGATGAAGATTTTATTAATTGATGACC  and 3-SalR-PstI—
AAAAACTGCAGGTCGTTTGATTATCTGCAACTCAG and HSC5 genomic DNA as a 
template salR was amplified and cloned into the PstI and XmnI sites of pMal-c2X.  
SalR-D53E and SalR-D53N were generated by splicing by overlap extension PCR and 
primers 3` salR D to E rev—GTTAAATTAATTTCAAGAAATATAATATCG and 
5` salR D to E fwd—CGATATTATATTGCTTGAAATTAATTTAAC, 5` salR D to N fwd—
CGATATTATATTGCTTAATATTAATTTAAC and 3` salR D to N rev—
GTTAAATTAATATTAAGCAAATATAATATCG. Proteins were purified as described 
previously (38) and stored at -80°C in 50% glycerol.   
The probe was amplified from HSC5 using primers 5-salYK-pro del1A—
CGCGGATCCCAGCTAATGAGATTATAGAGTC and 3-salY pro#4—
GCATAGAGCATTACCATC and digoxigenin-labeled (DIG) using a Roche second 
generation DIG labeling kit according to manufacturer’s instructions. 
EMSAs were conducted by mixing the specified amount of protein with a 
constant amount of probe in a binding buffer containing 100 mM HEPES (pH 7.2), 1 mM 
EDTA, 50 mM KCl, 50 mM MgCl2, 1mM dithiothreitol, and 30% (vol/vol) glycerol for 30 
min at room temperature. For reactions with competitor DNA, an excess of unlabeled 
probe was used as a specific competitor, and salmon sperm DNA was used as a 
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nonspecific competitor. The samples were loaded onto a 6% polyacrylamide native gel 
consisting of 6% (vol/vol) polyacrylamide, 44.5 mM Tris base, 44.5 mM boric acid, and 1 
mM EDTA, pre-run at 4°C and 150V. Electrophoresis was performed at 4°C at 180V for 
10 minutes and 300V for 25 minutes. The gel was then transferred to a nylon 
membrane (Santa Cruz) using a semidry transfer apparatus (BioRad).  The membrane 
was UV crosslinked for 15 minutes followed by blocking in 4% milk and 0.1 M maleic 
acid buffer for 30 minutes.  Alkaline phosphatase conjugated anti-DIG antibody was 
diluted 1:10,000 in 4% milk 0.1M maleic acid buffer and incubated with the membrane 
for 30 minutes. The membrane was washed three times in 0.1M maleic acid 
supplemented with 0.03% Tween-20.  Chemiluminescent detection was performed with 
CDP-Star (Roche) according to the manufacturer’s instructions, followed by exposure to 
X-ray film.  
Ex vivo human whole blood infections: 
Blood was isolated from healthy volunteers using the vacutainer system (BD) and 
collected in heparinized tubes (BD).  S. pyogenes overnight cultures were diluted 1:50 
in fresh THY and grown to midlog phase.  Cultures were normalized to an absorbance 
of OD600=0.3=108 cfu per mL in phosphate buffered saline (PBS) and serially diluted in 
PBS to 104 cfu/mL.  Ten microliters (100 cfu) of culture was added to 1mL of blood in a 
1.7 mL tube in triplicate.  Tubes were incubated at 37 degrees C for 3 hours with end 
over end rotation.  Following incubation, the cfu/mL was determined by serial dilution on 
THY agar plates. 
Human polymorphonuclear (PMN) cell infections: 
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Human PMNs were isolated and infected as described previously (120). Blood 
was isolated from healthy volunteers using the vacutainer system (BD) and heparinized 
tubes (BD) and mixed in equal volumes with 3% dextran (MP Biomedicals) in saline 
using 50-ml conical tubes to sediment red blood cells. The remaining cells were 
centrifuged at 800 x g at 4°C. Pellets were resuspended in 35 ml of 0.9% NaCl, and a 
10-ml underlay of Ficoll-Paque (GE Healthcare) was applied. This was centrifuged for 
30 min at 410 x g in a swinging bucket rotor at room temperature to separate out the 
granulocyte cell fraction. The supernatant was gently aspirated. Remaining red blood 
cells were lysed by resuspension of the pellet with 10 ml sterile H2O for 28 seconds, 
and isotonicity was quickly restored by adding 10 ml 1.8% NaCl. Purified PMNs were 
centrifuged at 500 x g and resuspended in 3 ml DMEM.  For infections, PMNs were 
diluted to a final concentration of 1x 106 cells per mL in DMEM with 50% human serum.  
Overnight cultures of S. pyogenes were diluted 1:50 in fresh THY and grown to midlog 
phase.  Cultures were normalized to an absorbance of OD600=0.3=108/mL in PBS.  
PMNs were infected at an multiplicity of infection (MOI) of 1 and control tubes of 50% 
human serum 50% DMEM were inoculated with an equal concentration of bacteria and 
were incubated 3 hours with end over end rotation at 37 degrees.  Following incubation, 
cfu/mL was determined by serial dilution on THY plates.  Percent survival was 
calculated by comparing cfu in cultures containing PMNs to cfu in cultures in 50% 
serum 50% DMEM with no PMNs.  
Zebrafish infections: 
Overnight S. pyogenes cultures were diluted 1:50 and grown to midlog phase in 
fresh THY.  Cultures were normalized to an absorbance of OD600=0.3=108/mL in THY 
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and diluted 1:10 in THY.  Ten microliters of bacteria (105 cfu) was injected into the 
dorsal muscle of anesthetized adult zebrafish.  Six fish were infected per strain and 
either survival monitored over 6 days post infection, or 24 hours post infection, fish were 
sacrificed and spleens aseptically removed and homogenized in PBS.  Homogenate 
was serially diluted and plated for viable cfu on CNA plates (Acumedia). 
Alkaline phosphatase reporter assay: 
S. pyogenes strains harboring plasmids pMNN1-salKR pro or pMNN1-salKR del2 
short pro (52) were grown overnight in THY supplemented with selective antibiotics, and 
overnight cultures diluted 1:50 in THY supplemented with selective antibiotics.  Cultures 
were grown to midlog phase (OD600 approximately 0.3) and concentrated to 
OD600=0.75.  Fifty microliters of culture was added to 200 µL 1-mg/ml p-
nitrophenylphosphate (Sigma) dissolved in 1 M Tris (pH 8) in triplicate in a 96 well plate.  
Reaction was incubated in the dark one hour at room temperature.  Following reaction, 
three optical densities (OD405, OD550, and OD600) were measured using a 
spectrophotometric plate reader (VersaMax). Alkaline phosphatase activity was 
determined using the following formula: [OD405 x(1.75 - OD550)]/(volume x time x 
OD600) x 1,000. 
Results: 
SalR binding to salKR promoter: 
Previous data showed that transcription from the salKR promoter was increased 
in a salKR deletion strain, suggesting a role of this two-component system in repression 
of this promoter (52).  In order to further examine this effect, we first tried to determine 
the conditions necessary for specific SalR protein binding by EMSA.  Previous analyses 
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had failed to find conditions necessary for specific binding.  Typically, two-component 
signaling systems activate transcription when the sensor kinase phosphorylates the 
response regulator.  We examined in vitro binding of the purified SalR protein to the 
salKR promoter probe after pre-incubation with the small molecule phosphate donor 
acetyl phosphate.  With both SalR and SalR pre-incubated with acetyl phosphate the 
non-specific unlabeled DNA is effectively able to compete the labeled probe out of the 
protein-DNA complex (Data not shown).  These results indicate that the addition of 
phosphorylated SalR protein does not stimulate a specific binding event. 
Repsonse regulators are phosphorylated by the sensor kinase on a specific 
aspartic acid residue, in the case of SalR, Asp-53.  In other two-component systems, 
mutation of this residue to an asparagine makes the protein unable to be 
phosphorylated, while mutation of this residue to a glutamate (phosphomimic) makes 
this protein act as if it is constitutively phosphorylated. To determine if SalR requires 
phosphorylation to specifically bind DNA, these mutations were constructed in the Asp-
53 residue. Comparison of the binding potential of these three purified proteins by 
EMSA indicated better apparent binding of the SalR-D53E phosphomimic compared to 
the wild type or SalR-D53N phosphomutant (Data not shown).  However, neither of 
these mutant proteins was capable of specific binding of the probe (Data not shown).  
Therefore, specific binding conditions of SalR are still unknown.   
Role(s) of SalA in septic infection: 
The 42 amino acid S. pyogenes SalA peptide is the homolog of the S. salivarius 
Salivaricin A lantibiotic.  Disruptions of the salM and salT genes lead to no active 
lantibiotic production by S. pyogenes.  However, previous data (52) showed that 
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transcription from the salKR promoter is increased in a salA deletion strain, and even 
further increased in a salA salKR double deletion strain, indicating that the SalA peptide 
serves a role in transcription and may function cooperatively with the SalKR proteins.  
To examine the role of the SalA peptide, alone and in combination with SalKR, in 
virulence we performed ex vivo human whole blood infections (Figure 30).  Wild type S. 
pyogenes is able to grow over two logs in three hours in human blood.  The growth of 
the salA deletion strain and the salKR deletion strain is approximately one log less than 
the growth of the wild type strain.  This attenuation is significant and indicates that the 
SalA peptide and the SalKR two component signaling system are key for growth during 
a septic infection.  The salA salKR double deletion strain not only cannot grow in human 
blood, it is in fact killed.  To determine the extent of the attenuation of the double mutant 
strain, further ex vivo blood infections were performed with an inoculum two logs higher 
(Figure 31).  With the higher inoculum the salA salKR double mutant strain was seen to 
have a two log reduction in cfu in human blood.  These data indicate that SalA acts 
synergistically with SalKR in promoting bacterial survival in a septic infection. 
To further examine the role of SalA and SalKR alone and in combination in septic 
infection we examined the ability of these mutant strains to survive in a human PMN 
infection model (Figure 32).  The salA and salKR single deletion strains are significantly 
attenuated compared to the wild type strain in ability to survive in human PMNs in fifty 
percent serum, compared to growth in fifty percent human serum alone. The salA salKR 
double mutant strain is also significantly attenuated compared to the wild type strain, but 




Figure 30: Human whole blood bactericidal assay. Bacterial growth in heparinized 
human whole blood over 3 hours. Average of 4 biological replicates, each having 3 
technical replicates. 100 cfu inoculum. *p<0.05, **p<0.01
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Figure 31: Human whole blood bactericidal assay. Bacterial growth in heparinized 
human whole blood over 3 hours. Trend representative of 3 biological replicates, each 




Figure 32: Human PMN infection. Bacterial survival over 3 hours in 50% human 
serum with 106 PMNs per mL compared to survival in 50% human serum alone.   
Average of 4 biological replicates each with 3 technical replicates. *p<0.05, **p<0.01.  
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indicates that the cooperative action of SalA and SalKR promoting survival in human 
whole blood is not evident in a PMN infection.  The factor present in whole blood that is 
missing in PMNs in fifty percent human serum that causes this effect is yet to be 
determined. 
Role(s) of SalZ in virulence and regulation of the sal locus: 
SalZ is a 66 amino acid peptide of unknown function encoded at the 3’ end of the 
sal locus. To explore the functions of SalZ in transcription and virulence we generated a 
salZ-insert strain. First we examined the ability of this mutant strain to survive in an ex 
vivo human whole blood infection (Figure 33).  The salZ-insert strain is about a half log 
attenuated in ability to grow in this assay, indicating an important role for SalZ in 
bacterial growth in a septic infection.   
Next we examined the ability of the salZ-insert strain to cause a lethal infection in 
a whole animal model of disease.  Following intramuscular infection of zebrafish with 
the wild type or salZ-insert strain, fish were monitored for survival for six days (Figure 
34).  Fish infected with wild type S. pyogenes succumb rapidly to infection and exhibit 
only thirty percent survival six days post infection.  Fish infected with the salZ-insert 
strain exhibited significantly attenuated survival on days one, two, four, five, and six post 
infection, with eighty percent of fish surviving six days post infection.  This data 
indicates that SalZ is important for the ability for S. pyogenes to cause lethal infection in 
a zebrafish model of myonecrosis. 
To further assess the role of SalZ in the ability to cause disease in the zebrafish 
model we examined bacterial dissemination to the zebrafish spleen at twenty-four hours 




Figure 33: Human whole blood bactericidal assay. Bacterial growth in heparinized 
human whole blood over 3 hours. Average of 4 biological replicates, each having three 




Figure 34: Zebrafish survival. Percent zebrafish survival following 105 cfu 





Figure 35: Dissemination to zebrafish spleen. 24 hours post 105 cfu intramuscular 
injection, viable cfu in the spleen. Each dot represents one fish and the bar represents 
the mean. N=24 fish per strain.  *p=0.014  
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spleen compared to the wild type, further supporting a key role for this peptide in S. 
pyogenes systemic infection. 
Lastly, we explored the role of SalZ in transcription of the salKR promoter, using 
an alkaline phosphatase reporter assay comparing transcription in the salZ-insert strain 
with transcription in the wild type and salKR deletion strains (Figure 36).  We examined 
both the full-length salKR full promoter and the salKR del2 short promoter fusions (52).  
The salKR pro del2 short was previously identified as not having any SalKR repression 
sites (52).  The salKR full promoter showed higher activity in the salKR deletion strain 
than in the wild type, yet in the salZ-insert strain, transcription of the reporter is 
significantly reduced.  This supports a role for SalZ in transcriptional activation of this 
promoter.  The salKR del2 short promoter also showed lower activity in the salZ-insert 
strain when compared to transcription in the wild type or salKR deletion strains, which 
as shown previously are not significantly different from each other.  Transcription of the 
salKR del2 short promoter is significantly higher than that of the salKR full promoter in 
the salZ-insert strain.  This suggests that the salKR del2 short promoter does have 
regulatory sites that are SalZ responsive, that are separate from the SalKR responsive 
sites.  However, we have not ruled out the fact that all transcription is attenuated in the 
salZ-insert strain, or the alkaline phosphatase enzyme is less stable in the salZ-insert 
strain. 
Discussion: 
The work described here shows that phosphorylation of SalR does increase 
apparent binding, but does not lead to specific DNA binding in EMSAs.  Further work 





Figure 36: Promoter activity. Promoter activity by alkaline phosphatase assay of the 
salKR full and salKRdel2 short promoters in the wild type, ΔsalKR, and salZ-insert 




possibility is that the peptides of the sal locus, SalA and/or SalZ, could act as cofactors.  
The combinational effects of SalA and SalKR in transcription (52) and in virulence (this 
work) suggest an interaction between these proteins.  Alternatively, SalA could be 
sensed through SalK and signal to SalR as occurs in S. salivarius (60).  However, due 
to the interruption of the salT gene in S. pyogenes, SalA may not be exported and may 
be accessible to SalR to act as a cofactor in DNA binding and transcription.  The role of 
SalZ is still unknown, and it could serve as a transcriptional cofactor as well.  The fact 
that transcription from the salKR promoter increases in a salA deletion strain and 
decreases in a salZ-insert strain, suggests an intriguing possibility of one peptide acting 
as a positive cofactor and another acting as a negative cofactor to tightly modulate 
transcription of this locus. 
Both peptides of the sal locus, SalA and SalZ, have a role in virulence of S. 
pyogenes.  SalA and SalKR act cooperatively to promote bacterial survival in human 
whole blood, but not in promotion of survival in a human PMN infection model.  Further 
work to elucidate the factor(s) present in human whole blood not present in a PMN 
fraction with 50% human serum that allow this effect could lead to a better 
understanding of S. pyogenes virulence in septic disease.  The role of monocytes would 
be especially interesting to investigate, as the role of macrophages, the monocytes of 
tissues, is well understood as a host cell for S. pyogenes during infection (121-123). 
SalZ contributes to virulence in an ex vivo human whole blood model and in models of 
zebrafish lethal infection and dissemination to the zebrafish spleen.  Further work 




CHAPTER 6: GENERAL CONCLUSIONS 
Roles of CpsA and LytR in modification of the Streptococcus agalactiae cell 
envelope: 
The body of work described here showed that modification of either the 
extracellular domain of the CpsA protein or the leucine zipper motif of the CpsA protein 
had significant effects on the S. agalactiae capsule and cell wall.  Moreover, strains 
expressing the truncated CpsA protein are attenuated in virulence, suggesting a role for 
the extracellular domain in pathogenesis.  Similarly, complete deletion of the cpsA gene 
or insertional mutagenesis of the lytR gene alone or in combination had effects on the 
capsule and cell wall and in virulence of S agalactiae.  This leads to a model (Figure 37) 
of CpsA having multiple binding partners interacting with each of the domains, leucine 
zipper motif, accessory domain and LCP domain, and potential direct or indirect 
interactions with LytR. 
The CpsA and LytR proteins are both members of the LCP family of proteins.  
These proteins are implicated in cell envelope maintenance in many Gram-positive 
species (34, 35, 37, 38, 82, 85, 86, 88-93, 112, 115, 116, 124-126).  Targeting and 
inhibition of LCP proteins could lead to a better understanding of Gram-positive cell 
envelope biogenesis and virulence mechanisms.  Multiple mutations of LCP family 
members in the same strain could provide information on how these proteins can act 
alone or in combination, and if they can compensate for each other. 
The accessory domain is unique to the CpsA protein members of the LCP family 
(34).  Our data indicates that the accessory domain, when expressed in the absence of 





Figure 37: Model of CpsA function and hypothesized interactions.  
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negative effect when expressed in the wild type strain and an inability to complement a 
cpsA deletion strain.  This suggests that the two extracellular domains of CpsA act 
independently, and suggests a model for differential regulation of capsule expression in 
response to environmental signaling. While the LCP domain can interact with a certain 
set of binding partners, during conditions requiring the expression of less capsule a 
different set of binding partners is engaged with the accessory domain, leading to a 
decrease in capsule expression.  Further work is needed to determine the binding 
partners of the extracellular domains of CpsA. 
The ligase to link the polysaccharide subunits of the capsule to the peptidoglycan 
cell wall is as of yet unknown.  The lack of an uncharacterized gene in the locus could 
indicate that this function is accomplished by one of the previously characterized 
proteins of the cps locus acting in a bi-functional manner.  CpsA is potentially this 
ligase.  Further work to determine if the CpsA protein could carry out this function would 
be to examine if strains expressing mutant CpsA are unable, or less able, to attach 
capsule intermediates to the cell wall.  Immuno-detection of capsule in whole cell and 
culture supernatants could determine if the capsule is being released from the lipid 
carrier but unable to be attached to the cell wall, as seen in Staphylococcus aureus 
mutants that release teichoic acids into the culture supernatant (115).  Additionally, the 
capsule intermediates could be unable to be released from the lipid carrier.  Immuno-
detection of capsule in whole cell, cell wall and cell membrane fractions of strains 
expressing a mutant form of the CpsA protein should be performed to determine if CpsA 
plays a role in this process. 
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The S. pneumoniae Cps2A crystal structure contained undecaprenyl-
pyrophosphate (undec-PP) (35, 82), indicating that Cps2A is capable of interacting with 
and potentially catalyzing a reaction with undec-PP.  Inhibition of an LCP protein could 
be accomplished by blocking the interaction of the protein with the lipid carrier to 
prevent linkage of the polysaccharide to the cell wall.  Our data, showing localization of 
FITC-CpsA peptide at the midcell/septal region, and the FITC-CpsA peptide binding 
only to growing bacteria, could mean the peptide is binding undec-PP or a related 
compound since free undec-PP is only available during active building of the cell wall.  
Since undec-PP is a low concentration intermediate, and important to both capsule and 
peptidoglycan synthesis (33) an inhibition of recycling of undec-PP by an aberrant CpsA 
protein could be preventing proper peptidoglycan assembly, and therefore leading to the 
cell wall cell division abnormalities of our truncations and leucine zipper mutants. 
Many leucine zipper motif proteins function at the divisisome (105-107) and in 
regulation of cell size and shape (108, 109), also indicating a function for the leucine 
zipper motif in cell division.  Our data show that mutation of the leucine zipper motif in 
the CpsA protein makes it unable to complement a cpsA deletion strain for capsule 
expression or cell wall morphology.  Additionally, the leucine zipper CpsA mutant, when 
expressed episomally in the wild type strain, causes a dominant negative effect on 
capsule expression and cell wall morphology.  Our data show that the wild type CpsA 
protein is capable of multimerization.  Further work needs to be done to determine if the 
leucine zipper mutant CpsA interferes with multimerization of the wild type CpsA 
protein, or if the leucine zipper mutant CpsA interferes with interaction of wild type CpsA 
protein with its normal binding partners.  In addition, we do not know the identity of the 
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CpsA protein binding partners.  Bioinformatic searches for membrane spanning leucine 
zipper motifs in other GBS proteins could suggest these binding partners, followed by 
confirmation by cross-linking and co-immunoprecipitaion and/or by purifying the proteins 
and doing isothermal titration calorimetry. 
Our data indicating that the dominant negative function of the truncated CpsA 
protein can occur through (1) expression of truncated protein, (2) addition of purified 
protein or (3) addition of synthetic peptide to wild type cultures provides new information 
for understanding of cell envelope biogenesis and for therapeutics against GBS 
disease.  Extracellular inhibition of an LCP protein through interference with 
extracellular domains could help identify the extracellular binding partners of these 
proteins and lead to a better understanding of the Gram-positive cell envelope, including 
how it is synthesized and regulated.  Additionally, functional inhibition of LCP domain 
containing proteins could have a therapeutic role in treating disease. 
Current strategies for prevention of GBS disease rely on antibiotic treatment of 
women during labor and delivery.  These strategies have multiple weaknesses (4, 6, 17, 
21, 127) in that they do not prevent chorioamniosis or late onset neonatal disease and 
have consequences to the maternal and neonatal microflora.  Ability to use a dominant 
negative factor that acts extracellularly as a topical treatment just prior to delivery to 
block capsule production by GBS could render the bacteria aspirated by the neonate 
avirulent.  Additionally, the dominant negative factor caused cell wall changes that could 
render the bacteria more susceptible to antibiotics or components of the immune 
system, which would make an infection more treatable.  If a dominant negative factor is 
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capable of acting against multiple bacterial species, then this treatment could be a 
widespread therapeutic agent. 
Virulence signaling of the Streptococcus pyogenes salivaricin locus: 
Here we demonstrated that the peptides of the sal locus, SalA and SalZ have 
important roles in virulence of S. pyogenes.  One possible role for these peptides is in 
transcriptional control of the locus.  Transcription from the salKR promoter is increased 
in both a salA deletion strain and a salKR deletion strain, and even further increased in 
a salA salKR double deletion strain (52).  This work showed that transcription of the 
salKR promoter in a salZ-insert strain was reduced.  The differential transcription seen, 
combined with the inability to find specific in vitro binding conditions for SalR in EMSAs, 
suggests an intriguing scenario where each peptide is serving as a transcriptional 
cofactor, but in opposite roles to allow differential transcription of the sal locus.  We 
would need to purify these peptides and add them to the EMSAs to determine if SalA 
and/or SalZ are acting as peptide cofactors in SalR binding to DNA.  Peptides can act 
as transcriptional co-repressors or anti-repressors (66). 
Alternatively, the peptides could serve a role as pheromones and act indirectly at 
the transcriptional level through interaction with SalK, which would change the 
phosphorylation state of SalR and differentially regulate transcription. Here we 
demonstrate that phosphomimic SalRD53E had increased apparent binding of the salKR 
promoter probe in vitro. To determine if signaling through SalK to change the SalR 
phosphorylation state is the mechanism of SalA and SalZ action we would have to 
determine if either peptide interacts directly with SalK, doing in vitro and in vivo 
crosslinking, or isothermal titration calorimetry with purified SalK and purified peptide to 
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determine if they interact. The roles of peptides in signaling by Gram-positive bacteria is 
well characterized (49, 58, 60, 62-65, 67, 128) and roles in virulence specifically (49, 60, 
63, 128). 
Additionally, we could examine the role of the phosphorylation state of the SalR 
response regulator protein through allelic replacement of salR with a point mutant that is 
translated into a protein that is incapable of being phosphorylated by SalK, SalRD53N, or 
one that acts constitutively phosphorylated, SalRD53E.  Chromosomal salR 
phosphomutant and phosphomimic strains could be examined for transcriptional 
regulation of the sal locus genes, and also to determine other potential targets of SalKR 
regulation.  The ability for two component signaling systems to cross-talk in vivo and 
regulate multiple targets is increasingly appreciated in multiple bacterial species (129-
135). 
The synergistic effects of the SalA peptide and the SalKR proteins in promoting 
bacterial survival in human whole blood is another avenue for future work.  
Determination of the factor that is present in blood that contributes to this effect could 
give key insights into septic infection by S. pyogenes.  Additionally, strains with 
mutations in salA and salZ, or in salKR and salZ, or in all of salA, salKR, and salZ  
should be generated to determine further potential combinational roles of these peptides 
and two-component system in virulence by S. pyogenes. 
The ability to interrupt virulence signaling could lead to an important 
understanding of virulence mechanisms of S. pyogenes, and could lead to clinical 
interventions to treat invasive S. pyogenes disease.  Two component systems are an 
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CHAPTER 7: FUTURE DIRECTIONS 
Effects of extracellular domain of CpsA on GBS cell envelope: 
 Follow up work on this chapter’s topic should be focused on the CpsA peptide.  
Firstly, narrow down what portion of this peptide is necessary and sufficient for capsule 
inhibition by examining wild type cultures grown with shorter versions of this peptide for 
capsule expression and chain length phenotypes.  Additionally, determination of the 
binding partner(s) of the peptide would be helpful to determine the binding partners of 
CpsA in proper regulation of the GBS cell envelope.   
 Additionally, a peptide corresponding to amino acids 153-187 should be 
constructed and wild type cultures grown with this peptide examined for capsule 
expression and chain length phenotypes.  Episomal expression in the wild type strain of 
a CpsA with truncation of these amino acids showed they too had a role in the dominant 
negative capsule expression phenotype.  Examination of wild type bacteria grown with 
this peptide alone, or with this and the CpsA peptide examined in this chapter, should 
be undertaken to determine the effects on capsule expression and cell wall integrity.  If 
an effect is seen, the binding partner(s) of this peptide should be determined to further 
understand the binding partners of CpsA in cell envelope regulation. 
 Other work should be undertaken to determine the effects on the cell wall.  
Transmission electron microscopy (TEM) to observe the cell wall in mutant strains 
expressing truncated CpsA, and of wild type strains treated with the peptide, should be 
performed.  This could verify the fluorescent vancomycin data indicating cell wall 
thickness abnormalities and aberrant division septum formation.  Additionally, the cell 
wall integrity can be examined by treating strains expressing truncated CpsA, or 
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cultured with CpsA peptide, with cell wall targeting antimicrobials, and cell membrane 
disrupting chemicals such as detergents and osmotic agents.   
Effects of the leucine zipper motif of CpsA on GBS cell envelope: 
 Further work needs to be done to see if the leucine zipper motif is acting to cause 
specific binding of DNA at the cpsA promoter.  This will require purification of a stable 
leucine zipper mutant CpsA protein to perform electrophoretic mobility shift assays 
(EMSAs).  If the FLAG-tagged leucine zipper mutant CpsA is also found to be unstable 
in vitro, purified membrane fraction containing CpsA or leucine zipper mutant CpsA 
should be used in EMSAs.   
Also, further work on the multimerization of CpsA needs to be done.  Better 
cross-linking in vivo, either in E. coli or ideally in GBS lysates, needs to be performed to 
see clear multimers of CpsA and determine the role of the leucine zipper motif.  Better 
in vitro crosslinking and isothermal titration calorimetry (ITC) should be performed to 
determine mulimerization status of purified protein. 
Additionally the binding partners of CpsA need to be determined.  Co-
immunoprecipitation of both full length and CpsA-117 with and without the leucine 
zipper motif will identify the binding partners of CpsA that bind the extracellular domain 
(interact with CpsA full, and CpsA-leu zip-full, but not the CpsA-117 truncations) and 
that bind the leucine zipper motif (those that interact with CpsA full and CpsA-117, but 
not the leucine zipper mutants).  Additionally, binding partners that interact at the 
leucine zipper motif could be predicted by bioinformatics identifying transmembrane 
leucine zipper motifs in other GBS proteins and further analyzed. 
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Lastly, analysis of the role of the leucine zipper motif on cell wall stability should 
be performed. TEM of cultures episomally expressing leucine zipper mutant CpsA 
should be performed to look for cell wall thickness and cell division abnormalities.  Also, 
mutants episomally expressing leucine zipper mutant CpsA should be examined for 
autolysis phenotypes and for sensitivities to cell wall and membrane targeting 
antimicrobials. 
Role of LytR in cell envelope maintenance of GBS: 
 This work is still preliminary, but there are several interesting avenues to pursue.  
Both the CpsA and LytR proteins contain the conserved LCP domain. If this domain is 
the functional enzymatic part of the protein it would be interesting to see how the CpsA 
protein truncations perform in the lytR::pUC and ΔcpsA lytR::pUC strain backgrounds.  
An unexplained finding from our work with the strain expressing the CpsA-117 
truncation is that episomal expression of this protein, which has the entire extracellular 
domain of CpsA removed, is able to complement the cpsA deletion strain for capsule 
expression, but it is unclear by what mechanism.  Perhaps the LCP domain of the LytR 
protein is capable of functionally compensating for the missing LCP domain of the 
CpsA-117 protein truncation.  Additionally, we were unable to explain the mechanism of 
the dominant negative effect of episomal expression of CpsA truncations containing all 
or part of the accessory domain in the absence of the LCP domain.  Expression of these 
truncations in the lytR::pUC and ΔcpsA lytR::pUC strains could further elucidate this 
mechanism since there would not be the confounding LCP domain of the LytR protein 
present.   
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The synthetic CpsA peptide should also be examined with the lytR::pUC and 
ΔcpsA lytR::pUC strains.  This could determine if the synthetic peptide is interacting with 
a common substrate/binding partner of both of the LytR and CpsA proteins or if it is 
interacting with a unique substrate/binding partner of CpsA.  If found to have 
promiscuous activity against multiple LCP family members of the same species, this 
peptide could even have therapeutic implications against multiple Gram-positive 
bacterial pathogens. 
Lastly, a strain with a triple mutation in the genes encoding all three LCP family 
members of S. agalactiae should be produced.   This could further delineate the 
contributions of each member of the LCP family in GBS and give insight into its cell 
envelope biosynthesis, and cell division regulation.   
Virulence signaling of the Streptococcus pyogenes salivaricin locus:  
Specific binding conditions for SalR to the salKR promoter need to be 
determined.  Optimization of the binding buffer is required. The current binding buffer 
contains too much glycerol, and both magnesium and EDTA, which chelates 
magnesium which negates the potential for magnesium to be acting as a cofactor.  
Magnesium was added to the binding buffer after preliminary data (P. Namprachan-
Frantz, unpublished data) indicated enhanced transcription of the salKR promoter in 
alkaline phosphatase assays of S. pyogenes promoter-reporter strains grown in the 
presence of magnesium.  However, magnesium is a cofactor for many nucleases, so 
inclusion of magnesium in the binding buffer should be done with caution, to avoid 
possible activity of contaminating nucleases.  Additionally, all binding buffers should 
also contain non-specific DNA, salmon sperm or poly dAT, and protein, BSA.  Also, a 
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range of ionic concentrations should be examined to optimize binding.  Additionally, the 
potential for both SalA and/or SalZ to serve as transcriptional cofactors needs to be 
examined.  Purification of these peptides and inclusion in binding reactions should be 
performed. 
Further work could be done in examination of transcription of this locus and 
virulence by replacing salR on the chromosome with the phosphomutant and 
phosphomimic point mutants.  These constitutively unresponsive, or responsive, 
proteins would allow us to see the role of SalR phosphorylation in virulence, using ex 
vivo human blood and also zebrafish models of disease, and to examine transcription of 






APPENDIX: ZEBRAFISH AS A MODEL FOR ZOONOTIC AQUATIC PATHOGENS 
This review article was published in Developmental and Comparative Immunology, 
Volume 46, pp 96-107. 
Abstract  
 Aquatic habitats harbor a multitude of bacterial species.  Many of these bacteria 
can act as pathogens to aquatic species and/or non-aquatic organisms, including 
humans, that come into contact with contaminated water sources or colonized aquatic 
organisms.  In many instances, the bacteria are not pathogenic to the aquatic species 
they colonize and are only considered pathogens when they come into contact with 
humans. There is a general lack of knowledge about how the environmental lifestyle of 
these pathogens allows them to persist, replicate and produce the necessary 
pathogenic mechanisms to successfully transmit to the human host and cause disease.  
Recently, the zebrafish infectious disease model has emerged, as an ideal host for 
examining aquatic pathogens, not only while in the aquatic environment, but also during 
infection of the human host.  This review will focus on how the zebrafish has been used 
successfully to analyze the pathogenesis of aquatic pathogens.  
1. Introduction 
 Aquatic pathogens are found in all water environments including marine, 
freshwater, brackish water, sewage, ground and even drinking water. Seawater alone 
harbors about 100 million bacteria per liter (138).  Humans can be exposed to all of 
these aquatic sources through various activities, ranging from consumption of 
contaminated seafood, ingestion of contaminated drinking water, recreational activities 
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such as swimming, surfing, boating or fishing, exposure of open wounds to 
contaminated water sources or through handling of contaminated fish.   
 An important source of human pathogens from aquatic habitats is the many fish 
species that are used for food consumption.  Fish are an important part of the human 
diet worldwide and can therefore serve as vectors of human disease.  Extensive growth 
in the aquaculture industry in the last 30 years has come from an increased desire for 
lean protein and healthy fats, as well as depletion of fish species in natural waters from 
overfishing.  In addition, restrictive quotas have been imposed for many wild caught fish 
in certain geographical areas leading to a further decline in fish availability in the food 
supply.  To further increase overall production to meet the rising demand, fish farms 
often have overcrowded ponds that can serve as hot transmission sites for fish disease 
and serve as bacterial reservoirs that can be passed on to humans during food 
preparation.    In many parts of the world, fish that can harbor potential bacterial 
pathogens live in water supplies creating a reservoir that can be passed on to humans 
in drinking water.   Incidences have been reported in which the source of a bacterial 
disease outbreak in wild fish came from a nearby contaminated aquaculture facility 
(139).  Therefore, one of our major sources of protein can also be the origin for potential 
human pathogens as well as serve as a major contributor to contamination of essential 
water supplies. 
 For many years, zebrafish (Danio rerio) have served as an important tool of 
biomedical research, providing great advances in our understanding of vertebrate 
development and disease modeling.  Importantly, in recent years, zebrafish have been 
used to effectively model human infectious disease. Zebrafish symptoms closely reflect 
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those of diseased wild and farmed fish or clinical symptoms observed during human 
infections.   Zebrafish can also become colonized by some aquatic pathogens without 
succumbing to disease providing an excellent model for the role of fish as an 
“environmental reservoir” for aquatic pathogens. “Environmental reservoirs” describes 
locations that allow bacterial persistence and replication in the environment while 
favoring pathogen transmission to susceptible hosts (140).  This review will focus on 
recent research on zebrafish as experimental hosts of aquatic bacterial pathogens that 
can act as environmental vectors for human disease by colonization of both farmed and 
wild fish populations.  Furthermore, aquatic colonization models of human pathogens 
can provide information on environmental reservoirs of pathogens and how they 
contribute to transmission of human disease.  Of all the infectious diseases modeled 
using the zebrafish host, those diseases caused by aquatic organisms would appear to 
have the greatest potential to add to our knowledge of pathogenesis because of 
environmental niche they share.   
2. Utilizing zebrafish as an infectious disease model. 
 Natural pathogens of fish, such as Mycobacterium marinum and Streptococcus 
iniae, have been utilized with the zebrafish infectious disease model to provide excellent 
models for understanding the pathogenesis of human M. tuberculosis pathogenesis 
(see (141-147) for review and citations within) and human streptococcal systemic 
infections (45-47, 120, 148-150).  Using a model host allows comparison in side by-side 
infections of bacterial mutants with wild type bacteria to examine the role of virulence 
genes in aquatic and human disease.   Information gained from these analyses allows 
development of methods to better target infection either in the vector (fish) itself or in the 
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human or animal host.  One advantage of using the zebrafish as an infectious disease 
model is the ability to knockdown zebrafish genes using morpholino technology to 
suppress expression of a particular immune gene to determine its role in fighting 
disease.  Furthermore, vaccine and treatment strategies studied in the zebrafish can be 
translated to the fish farms and to the human clinics.  Consequently, the use of the 
zebrafish for analysis of aquatic pathogens makes it an ideal infectious disease model. 
 Zebrafish disease models have utilized multiple life stages of the host, from 
embryos to adults.  Because the innate immune system is active within 24 hours post 
fertilization (hpf) in zebrafish, but the adaptive is not completely developed until 3-4 
weeks later, important differences in required immune responses for fighting specific 
infections can be analyzed using the different stages of development.   
 Multiple methods of inoculation have also been used and depend on the ability of 
the pathogen to breach natural defense barriers of the zebrafish. The outer mucus layer 
of the zebrafish provides a natural barrier to infection, much as the mucous membranes 
in human tissues.  The epidermis and scales of the zebrafish also act as a protective 
layer just as the epidermis and dead skin cell layer act as a barrier to pathogens in 
humans.  Natural routes of infection in the model system include simply adding bacteria 
to the tank water; bath immersion, in which the zebrafish are placed for a limited period 
of time in a high concentration of bacteria and then placed into fresh tank water; and 
dermal abrasion prior to bath immersion. Fish can also be infected or colonized by the 
oro-gastric route, by being exposed to inoculated tank water or allowed to feed on 
inoculated food sources. All of these test the ability of the bacteria to breach natural 
barriers, or mimic inoculation conditions that would be encountered in the natural 
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aquatic environment.  However, they do not allow for an accurate measurement of the 
amount of bacteria delivered to the host.  
 Other methods of inoculation include oral gavage, in which bacteria are inserted 
into the esophagus through a small tube attached to a syringe (151, 152).  This allows 
inoculation into the gastrointestinal tract and is particularly important for analysis of 
pathogens that have a GI tropism.  Although this method does provide a bit more 
precision in determining the amount of bacteria inoculated, some of the inoculum can 
escape through the gills or be lost through the mouth.  Therefore, subsequent bacterial 
counts taken shortly after inoculation can be inconsistent.  
 The most common route of inoculation is injection of bacteria directly into the 
host, which gives reliable reproducible infection results, but is not a natural route of 
infection.  In adult zebrafish this includes intramuscular injection into the dorsal muscle 
or intraperitoneal injection into the peritoneum (153).  Microinjection is also used for 
larval infections where bacteria are inoculated into the otic vesicle, the yolk sac, tail 
muscle or the tail vein (154).   All of these can be used to mimic a certain type of 
infection and to ask a specific question about the ability of the pathogen to survive in a 
particular tissue or to disseminate to other tissue environments.   
3. Aquatic pathogens modeled in the Zebrafish 
 While mammalian models of human disease have proven invaluable in providing 
information on pathogenesis, they do not always accurately mimic disease symptoms 
that occur during human infections.  Furthermore, some human pathogens do not 
readily infect mice, rats or rabbits, as they are not natural pathogens or these 
organisms.  In the case of zoonotic infections, information on transmission from the 
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vector to the human host is completely lacking. Many questions remain about the ability 
of the pathogen to persist during the environmental stage or in an alternate host, often 
in a non-pathogenic state, before being transferred to humans.   Using the zebrafish to 
address these types of questions with aquatic pathogens provides an opportunity to 
acquire new knowledge that could be used to develop strategies to eliminate the 
pathogen before human exposure.  
3.1 Edwardsiella: 
 Edwardsiella tarda and Edwarsiella ictaluri can cause septicemia in fish 
populations from both freshwater and marine environments.  While E. ictaluri only 
infects fish, E. tarda is a zoonotic pathogen that can infect both fish and humans (155).  
Transmission to humans is through exposure to contaminated aquatic environments 
and infected fish or through ingestion of contaminated fish (155).  Gastroenteritis is the 
most common clinical syndrome observed in humans and can range from an 
asymptomatic carrier state to intestinal colitis (156).  E. tarda can also cause 
extraintestinal infections with soft tissue infections, meningitis, peritonitis, septicemia, 
bacteremia, endocarditis and urosepsis (157).  Although infections in humans are more 
rare than in fish, E. tarda septicemia infections occurring in individuals with impaired 
immune systems can be severe and result in high mortality rates up to 50% (155, 157, 
158). 
 Along with the Aeromonads, the Edwardsiella bacterial species cause the most 
severe morbidity and mortality in aquaculture (159).   Multiple species of fish are 
susceptible to edwardsiellosis including carp, tilapia, eel, catfish, mullet, salmon, trout 
and flounder.  Conditions most favorable for E. tarda infection include high temperature, 
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poor water quality and high organic content (159), conditions that can often occur in 
aquaculture farms without proper diligence to hygienic practices. The bacteria can 
survive in pond water and mud for long periods of time and can increase in 
concentration with increasing temperature and organic load (159).  The clinical 
pathology of edwarsiellosis includes small cutaneous lesions that can develop into large 
necrotic abscesses, petechial hemorrhaging of the fin and skin, rectal hernia and 
swelling of the abdomen due to fluid accumulation (160, 161).   The ability to survive 
outside the host provides an environmental reservoir that can lead to outbreaks of 
infection in the fish population, and subsequently humans, when the conditions are 
favorable. 
 Experimental infection analyses have shown zebrafish to be an effective 
experimental host for E. tarda infection, showing similar clinical pathology to that 
observed in naturally infected wild and farmed fish populations (161).  While larvae were 
susceptible to infection by bath immersion, adult zebrafish were only susceptible to 
infection if the dermis was abraded prior to bath immersion, or if injected with bacteria. 
Mortality was observed from all infection methods in both larvae and adult fish.   Gross 
symptoms in adult fish included discoloration and petechial hemorrhages at the site of 
wounding, if infected via the abrasion-bath immersion method, and distended abdomen 
and characteristic peri-anal edema, if infected by IP injection (161). The blood of 
infected fish contained inflammatory cells with intracellular bacteria in macrophages, 
similar to that shown in kidneys of experimentally infected rohu fish (159).   Infected 
larvae showed systemic inflammation, leading to epithelial and muscle tissue 
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destruction, and numerous inflammatory cells in the bloodstream, with intracellular 
bacteria in macrophages (161).  
 Although bath immersion mimics a more natural route of infection, modeling the 
environment of a fish farm, or site of high bacterial load in the natural environment, van 
Soest et al. (162) found that infection levels and especially immune responses following 
immersion in E. tarda culture are highly variable from fish to fish.   However, injection 
into the tail vein of the larva caused a more reproducible infectious dose and a more 
consistent induction of immune related genes.  While immersion resulted in a range of 
25-75% mortality, tail vein injection resulted in 100% mortality.  Therefore, while the 
zebrafish can be used to mimic natural infection routes of E. tarda that may occur in the 
environment, using methods that produce 100% inoculation (such as injection) allows 
experimental analysis of virulence pathologies and host response by bypassing the first 
protective barriers to infection.  Pro-inflammatory responses were measured on the 
single embryo level and showed a strong induction of the il-1b and mmp9 genes (162).  
Pressley et al. (2005) also showed a strong upregulaton of IL-1B in both E. tarda 
infected larvae and adult zebrafish, as well as an increase in TNFa (161).  The results of 
a microarray performed on RNA isolated from infected zebrafish larvae revealed a 
increased expression of genes involved in defense and regulation of the immune 
response (162).   Results from these types of analyses with zebrafish provide new 
information about host response to E. tarda infection allowing development of more 
effective treatments. 
 Using a responsive experimental host also allows for analysis and identification 
of major virulence genes in the pathogen.  Very little was known about the pathogenic 
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mechanisms of E. tarda until recently.   Using the zebrafish infectious disease model, 
several groups have been able to identify key factors in E. tarda pathogenesis.  Xiao et 
al. (2012) showed E. tarda encodes two catalases, enzymes that allow the bacteria to 
breakdown hydrogen peroxide.  Hydrogen peroxide is often the first line of defense 
used by the innate immune system against invading pathogens.   Comparison of 
zebrafish infections with an E. tarda wild type strain and a strain that had a knockout of 
one of the catalase genes showed partial attenuation, with an approximate 10-fold 
increase in LD50.  However, a strain with a deletion of both catalase genes showed a 
100-fold increase in LD50 (163).   Similarly, Wang et al. (2012) showed that deletion of 
the rpoN gene, which encodes an alternative sigma factor implicated in multiple species 
as a transcriptional regulator of virulence genes, had an 8-fold increase in LD50 
compared to infection with the wild type strain.  The ΔrpoN strain also had reduced 
ability to survive peroxide, acid, osmotic, and starvation stresses and produces less 
biofilm and chondroitinase, all of which could be implicated in virulence (106).   The 
invasin protein of E. tarda was examined for its role in virulence during zebrafish 
infection.  Both deletion and overexpression of the invasion gene was analyzed.  While 
deletion showed decreased virulence, most likely through reduced hemolytic activity 
and biofilm formation, overexpression of the invasin protein demonstrated higher 
adherence and internalization levels in cultured zebrafish epithelial cells (164).   
 Yu et al. (2012) took a different approach by analyzing the role in virulence of an 
antibiotic resistance plasmid (165).  Virulence genes are often encoded on these 
plasmids, leading to transfer of virulence genes between bacterial populations and 
increased survival of bacteria in environments with high antimicrobial concentrations 
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such as fish farms.  An E. tarda strain cured of an antibiotic resistance plasmid showed 
attenuation in mortality in zebrafish as well as goldfish and Japanese flounder.  
Subsequent sequencing of the plasmid identified 84 open reading frames, revealing that 
multiple virulence genes other than the genes for antibiotic resistance are encoded on 
the plasmid harbored by E. tarda (165).  All of these analyses provide new information 
on genes required for pathogenesis, identifying new targets for antimicrobial therapies. 
 A major reason for the success of the zebrafish infectious disease model is 
because their immune system is very similar to humans (150).  This means that they 
can also be a good model for vaccine development and analysis of immunization 
against infections.  In an effort to find a vaccine for E. tarda infections, Yang et al. 
(2013) examined the zebrafish immune response using a live attenuated E. tarda 
vaccine strain for immunization and a fully virulent E. tarda strain for the subsequent 
challenge.  The vaccination led to 78% of fish surviving a challenge 4 weeks post-
immunization whereas only 12% of naïve fish survived challenge.  Immunity was 
mediated through TLR5 signaling and activated a CD8+ T-cell response through cross-
presentation of extracellular antigen.  CD8+ responses were more induced during the 
challenge phase than the immunization phase.  Vaccination also induced specific 
antibody in the fish serum, indicating that this vaccination activated both cell and 
humoral mediated immunity (166). 
3.2 Aeromonas 
 Aeromonas species have had a devastating effect on the aquaculture industry 
with reports of major losses in fish populations worldwide resulting in great financial loss 
(167).  Disease states in fish from Aeromonas hydrophila infections range from 
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hemorrhagic septicemia, red sore disease and ulcerative infections in multiple species 
of fish (168).  Although the Aeromonads are mostly considered associated with aquatic 
environments i.e., found in fresh water, seawater, drinking water and groundwater, they 
are also ubiquitous in the environment, and are associated with a number of 
recreational habitats, animals and consumable products that can lead to human 
exposure and potential infection (168).  There are a plethora of clinical syndromes, both 
intestinal and extraintestinal, that Aeromonas can cause in humans ranging from 
relatively mild gastroenteritis to infections with high mortality rates such as septicemia, 
necrotizing fasciitis, and myonecrosis ((168) and the references within).  Serious wound 
infections can occur from simple abrasions if the affected area is exposed to 
contaminated water sources, such as streams, lakes and recreational waters.  
Therefore, aquatic habitats can serve as an environmental reservoir for human 
Aeromonas infection, which is now considered an emerging pathogens for humans 
(169). 
 A. hydrophila is also a natural pathogen of zebrafish, making it an excellent 
model for the study of pathogenesis. A recent outbreak of hemorragic disease in 
laboratory zebrafish was isolated and identified to be A. hydrophila (170).  Naïve fish 
challenged with this strain by either IP injection or a wound-immersion route quickly 
developed the same symptoms as fish in the original outbreak.  Importantly, injection 
with just the extracellular secreted products gave similar mortality, indicating that the 
major virulence factor(s) is secreted.  Live bacteria and their extracellular secreted 
products were hemolytic against fish blood and cytotoxic to cultured zebrafish kidney 
cells.  Pro-inflammatory cytokines (TNFa, IL-1b and IFNg) and iNOS were strongly 
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induced by infection with live bacteria as well as with extracellular secreted products 
alone.  These results strongly indicate that A. hydrophila causes disease by triggering 
massive inflammation, mediated by the extracellular secreted products (170).  In 
support of these results, when Li et al. (2011) focused on three known virulence factors 
of A. hydrophila: the aerolysin, the cytotoxic enterotoxin and a serine protease, it was 
found that these three factors act synergistically in causing disease (171).  Examining 
isolates encoding none of or only 1 or 2 of these virulence genes had similar LD50 when 
tested in a zebrafish model, whereas isolates with all three virulence genes had a 
reduced LD50. Isolates positive for all three virulence genes were also more hemolytic, 
more cytotoxic towards Vero cells, and had more proteolytic activity in their 
supernatants, suggesting that disease is caused by tissue destruction by these 
virulence factors (171). However, there were strain specific differences, indicating that 
other virulence factors, beyond the three tested, also play a role in disease. 
 Much work has been done on finding ways to combat A. hydrophila infection in 
aquaculture to preserve fish populations as well as circumvent transmission to humans.  
Antibiotic treatment is one of the major options for treating an infection.  However, use 
of inappropriate antibiotic treatment in the food supply has been highly controversial.  
One reason is that inappropriate antibiotic use can lead to development of antibiotic 
resistance in pathogens through selective mutations or transfer of antibiotic resistance 
genes between bacteria.  Cantas et al. recently utilized the zebrafish infectious disease 
model to examine the role of antibiotic use in treating A. hydrophila infection (172).   
Oral gavage was used to inoculate adult zebrafish with A. hydrophila leading to 
systemic disease.  Infected zebrafish were then treated with antibiotics that were either 
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effective for the infection or at sub-inhibitory levels leading to ineffective treatment.  
Expression of innate immunity genes in the gut of the zebrafish was then measured 
under the different conditions.  In addition, expression of bacterial antibiotic resistance 
plasmid transfer genes was examined to determine how the antibiotic treatments 
affected potential transfer of antibiotic resistance. Infection alone increased expression 
of IL-1β and IL-8, but not TNFα or complement factor C3.  Infection plus effective 
antibiotic treatments increased all four examined immune genes, as did ineffective 
treatment with trimethoprim, sulphonamide or flumequine, but ineffective doses of 
tetracycline reduced expression of TNFα and C3 below levels measured in untreated 
infected fish.  In addition, ineffective antibiotic treatment can also activate transfer genes 
of a bacterial antibiotic resistance plasmid, while transfer genes were repressed in 
bacteria during effective antibiotic treatment.  Taken together, using zebrafish and A. 
hydrophila as a model, this study demonstrated the danger in ineffective antibiotic 
treatment leading to activation of resistance plasmid transfer genes, and in the case of 
tetracycline, repression of immune genes, whereas effective antibiotic concentrations 
not only kill the pathogen, but block transfer of resistance plasmids and can activate 
innate immunity genes to help the immune system clear the infection.  This supports 
observations that single high dose antibiotic therapy can clear infection (172). 
 The zebrafish model has also been used to explore alternatives to antibiotic 
treatments to A. hydrophila infection.  Many bacteria use “quorum sensing” a signaling 
system based on population density to communicate with each other.  A. hydrophila use 
quorum sensing to regulate virulence gene expression using the signaling molecule acyl 
homoserine lactone (AHL) (81, 173, 174).   One alternative to antibiotic use would be to 
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block the quorum sensing signaling between bacteria using a treatment with an AHL 
degrading enzyme (lactonase), acting as a broad spectrum inhibitor of virulence.  
Zebrafish exposed to A. hydrophila infection by bath immersion that were subsequently 
fed with a fish food supplemented with an AHL lactonase showed significantly reduced 
mortality compared to fish not treated with the enzyme providing a new potential therapy 
for infection (175). 
 Vaccination methods in fish populations are also being pursued as a mechanism 
for combating A. hydrophila infection.  This reduces the dangers from broad scale 
antibiotic use in ponds, but is more labor-intensive as each fish needs to be treated.  
The zebrafish model has provided an excellent model for testing vaccination methods 
for many types of aquatic pathogens, including Aeromonas.  One way in which to 
provide immunity to a population without having to vaccinate every fish is to use a 
vaccine that can be provide immunity that is transferred from mother to offspring.  Wang 
et al. (2009) demonstrated that vaccination of breeding females with formalin-killed A. 
hydrophila provided significant protection to the embryos (176).  This was not mediated 
by maternal transfer of antibody, but rather by maternal transfer of complement 
components C3 and Bf.  Vaccination of breeding females caused a rise in C3 and Bf 
levels in both the whole body homogenate of the adult fish and in the extract of eggs 
produced by that fish. Treatment of the fish with an anti-C3 or anti-Bf antibody reversed 
these effects.   Embryos from vaccinated and unvaccinated fish were challenged with 
live, fully virulent A. hydrophila.  Embryos from vaccinated fish survived significantly 
more than those from unvaccinated fish. Embryos from vaccinated fish were able to kill 
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the bacteria, providing evidence that the maternal derived complement components are 
able to lyse the pathogen (176).    
 In a follow-up study, vaccination of female zebrafish with the hapten-carrier 
trinitrophenylated bovine serum albumin TNP-BSA raised a specific antibody response 
in the fish (106).  These antibodies were transferred to the offspring of vaccinated 
females.   Embryos from females vaccinated with TNP-BSA were less susceptible to A. 
hydrophila than embryos from unvaccinated females.  This protection was IgM specific, 
as an anti-IgM treatment blocked protection.  Embryos of vaccinated mothers were able 
to kill A. hydrophila suggesting that the protection is maternal antibody mediated 
bacterial lysis.  These were not A. hydrophila specific antibodies, indicating that these 
maternal antibodies were able to act non-specifically in protecting the embryo from 
water-borne infection.  This mechanism of specific maternal antibodies acting non-
specifically against bacterial pathogens, in addition to maternally derived natural 
antibodies, may protect embryos from water-borne infection until development of the 
adaptive immune system (106). 
3.3 Streptococcus 
 Streptococcosis in fish populations was first confirmed in Japan in the late 1950s 
(177).  Since that time, multiple species of streptococci have been found to infect fish 
populations, but the major cause of economic losses from streptococcosis in 
aquaculture and wild fish population are Streptococcus iniae and Streptococcus 
agalactiae.  Both of these pathogens can also cause disease in humans and the aquatic 
habitat can act as a reservoir for human infection. Here we will discuss reports of the 
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zebrafish infectious disease model to experimentally determine pathogenic mechanisms 
in both human and aquatic isolates of streptococci. 
3.3.1 Streptococcus iniae  
 The first report of Streptococcus iniae infection was in 1976 in a captive Amazon 
freshwater river dolphin in which subcutaneous lesions called “golf ball disease” were 
described (178).  However, in the last 35 years, S. iniae has emerged as a major finfish 
pathogen with a host range of over 27 species of fish from both freshwater and marine 
environments (179).  While wild fish populations are just as susceptible to S. iniae 
infections, the most devastating effects of this pathogen have been observed in 
aquaculture with an estimated economic loss of over 100 million worldwide (180).  
Although the type of disease presentation varies with fish species, most often a 
systemic infection occurs with accompanying meningitis and panophthalmitis (181).  In 
almost all cases, infection results in high morbidity and mortality. 
 S. iniae is also a zoonotic pathogen with the first reports of human infection 
occurring in 1995 after the handling of fresh fish from aquaculture (182).  Infection in 
humans is usually a result of handling of contaminated fish and sustaining an injury 
allowing access of the pathogen to the underlying dermis layer, usually of the hand.  
Resulting infection manifests as bacteremic cellulitis with the rare complications of 
endocarditis, meningitis, arthritis, sepsis and toxic shock in immunocompromised 
individuals (182-186).  Although there have only been about 30 reports of S. iniae 
infections in humans, it has been suggested that infections are most likely 
underreported because clinical identification relies on biochemical testing and S. iniae is 
currently not listed in commercial or clinical databases (185, 187). 
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 The first publication using zebrafish as an infectious disease model for 
streptococcosis demonstrated that the histopathology as well as the clinical symptoms 
of S. iniae disease mimicked that which was observed in farmed fish populations (149).  
Zebrafish succumbed to a systemic infection within 4 days post intramuscular injection 
with an LD50 of 5 x 103 cfu.  S. iniae was able to be isolated from the skin, heart, gall 
bladder and brain (149).   Subsequently, a large-scale screen investigating virulence 
factors in S. iniae highlighted the advantage of using the zebrafish infectious disease 
model (45).  A signature-tagged mutagenesis screen was performed to determine 
mutants that could not survive in the heart or the brain of the zebrafish at 24 hours.  The 
screen identified 41 mutants that were attenuated in the zebrafish host, 50% of which 
had homology to virulence genes from other streptococcal pathogens.  These results 
confirmed the effectiveness of the zebrafish disease model for identifying virulence 
genes required for infection in the host.  Importantly, 10 of the transposon insertions 
were found to be in the capsule operon of S. iniae, confirming the importance of capsule 
for systemic infections (45).  By comparing the sequence of the capsule operon of the 
9117 virulent S. iniae strain to a commensal strain of S. iniae isolated from healthy fish, 
Lowe et al. (2007) was able to show that the commensal strain had a large deletion in 
the capsule operon encompassing several important capsule synthesis genes (81).  In 
addition, the ability of various capsule mutants to survive in the presence of the wild 
type strain (competitive indices) or the ability to disseminate and survive in different 
tissue environments was examined using the adult zebrafish, providing new information 
on regions of the capsule operon required for virulence (81).   
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 To better determine the role of the innate immune system in protection from S. 
iniae infection, a zebrafish larvae model was employed to visualize host-pathogen 
interactions in real time.  An S. iniae wild type strain and a ΔcpsA capsule mutant strain 
were stained with the CellTracker red CMPTX dye prior to injection.  Three zebrafish 
larvae strains were used as hosts: the Tg(mpeg1:dendra2) (47) zebrafish line in which 
the macrophages are expressing EGFP; the Tg(mpx-dendra2) (188) zebrafish line in 
which the neutrophils are expressing EGFP; and the Tg(mpx:mCherry-2A-rac2-d57n) 
zebrafish line in which neutrophils are expressing the inhibitory Rac2(D57N) mutation 
making them unable to respond to inflammatory stimuli, including otic infection (141). 
Injections were into the otic vesicle so as to observe recruitment of macrophages and 
neutrophils to the site of infection, as the otic cavity is usually free of leukocytes (189).  
Injections of the wild type S. iniae into larvae were lethal within 24 hours, while over 
90% of larvae injected with the ΔcpsA mutant survived.  Both neutrophils and 
macrophages were visibly recruited to the site of infection and were observed to 
phagocytose bacteria.   While depletion of both macrophages and neutrophils using 
Pu.1 morpholino injection led to an increased survival of the larvae, using a strain with 
impaired neutrophil function, but normal macrophage function, revealed that neutrophils 
are essential for control of S. iniae wild type infection (47).  
 The cpsY gene, which is directly upstream of the capsule operon of S. iniae was 
originally thought to be involved with capsule expression because of its homology to the 
LysR transcriptional regulator family (190).   A cpsY deletion strain was also highly 
attenuated in the zebrafish infectious disease model and showed an inability to 
disseminate to the brain, a key factor in S. iniae pathogenesis in fish (81).   However, it 
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was determined that CpsY was not regulating capsule in S. iniae (81) or S. agalactiae 
(191) and was instead involved in methionine biosynthesis and uptake (192).  To 
elucidate the role of CpsY in pathogenesis, Allen and Neely (2011) combined in vitro 
whole blood and human neutrophil assays along with in vivo zebrafish infections to 
determine that CpsY is required for survival within neutrophils (120).   Subsequent 
research confirmed that in addition to methionine biosynthesis and uptake, CpsY 
stimulates cell wall stabilization through peptioglycan O-acetylation and repression of 
autolysins (193). Therefore, as was shown by the larval infection model detailed above 
(47), neutrophils play a key role in controlling infection of S. iniae; however, the 
pathogen has evolved specific mechanisms that allow survival in that environment.    
 In an effort to learn more about key virulence genes required for pathogenesis of 
S. iniae, Locke et al.(2008)  performed pyrosequencing of an S. iniae strain isolated 
from the brain of a diseased hybrid striped bass (K288) (148).  Their analysis revealed 
an M-like protein (called SiM), which had high homology to the well-studied surface-
anchored M protein from Streptococcus pyogenes that is required for virulence (194, 
195).  In addition, they identified a gene that encodes a protein homologous to the C5a 
peptidases found in both S. pyogenes and S. agalactiae that cleaves the 
chemoattractant C5a of the complement system (196).  In vivo analyses in zebrafish 
and hybrid striped bass of S. iniae mutants in these two identified genes showed that 
the SiM protein plays a role in virulence, while the C5a peptidase did not.  They further 
tested the SiM deletion strain as a vaccine candidate in the hybrid striped bass model 
and found it to be highly protective from a lethal dose of the wild type strain 90 days 
after vaccination (148). 
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 Lopez-Munoz utilized the zebrafish-S. iniae disease model to determine the role 
of zebrafish IFNs during infections (197). There results demonstrated that while both the 
group I and group II zfIFNs could protect against viral infection, only the group I zfIFN 
was able to protect zebrafish from S. iniae infection through the induction of 
proinflammatory genes.  Interestingly, they also found that unlike with mammalian IFN-
g, zfIFN-g was unable to produce the proinflammatory response to infections (197). 
3.3.2 Streptococcus agalactiae 
 Streptococcus agalactiae, better known as Group B Streptococcus, (GBS) is a 
Gram-positive pathogen responsible for human and agricultural disease. Of all the 
streptococcal species, S. agalactiae appears to have the broadest host range for 
pathogenesis, having been isolated from both cold-blooded aquatic organisms as well 
as warm-blooded terrestrial animals.  In humans, it is the leading cause of early onset 
neonatal sepsis and meningitis in the developed world (198).  GBS can also cause 
infections in non-pregnant adults and is considered as an emerging pathogen in 
immunocompromised and older individuals (199).  Outside of human infections, GBS is 
a major contributor to disease in agriculture, particularly bovine mastitis and fish sepsis.   
 Massive outbreaks of streptococcis caused by GBS have been observed in both 
farmed and wild fish populations worldwide (200).  There are also many reports 
examining the serotypes of strains isolated from different hosts to determine if certain 
serotypes are species specific(201, 202).  There are only 9 serotypes of GBS and those 
that are found to cause the most invasive disease in humans have also been isolated 
from aquatic mammals and fish (203).  One study identified eating colonized fish as a 
risk factor for human colonization of GBS (204). 
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 Patterson et al. (2012) used the streptococcal-zebrafish model (149) to 
investigate disease characteristics of GBS (205).  Zebrafish infected with high doses of 
GBS by either the intramuscular or intraperitoneal route succumb to infection, whereas 
fish infected with a low dose can clear the infection.  Bacteria are found within the blood 
immediately after IP injection and dissemination to the brain was observed within 2 
hours post injection.  Inflammation within the brain was observed grossly as cerebral 
edema with higher expression of inflammatory cytokines IL-1β and IL-6 within the brain 
compared to non-infected zebrafish (205).  Their study accurately models the symptoms 
and response to meningitis as observed in human GBS patients.  Mutations in virulence 
genes of GBS lead to attenuation in the zebrafish model, validating that factors 
important for human disease are also important for fish disease.  Deletion of the 
transcriptional activator of capsule production cpsA leads to increased survival of fish 
infected by the IM route (38) and cpsA mutants are attenuated in the ability to 
disseminate to the spleen, heart and brain (Fig A1, unpublished data from our lab).   
Mutations in the hemolysin cylE or a capsule transglycosylase cpsD or a two-
component system responsible for virulence regulation covRS were attenuated in their 
ability to cause meningitis in the zebrafish, whereas the hypervirulent in humans COH1 
strain caused increased concentration of GBS in the blood and brain, resulting in 
increased lethality in zebrafish (205). 
3.4 Mycobacteria 
 Mycobacterium marinum has been analyzed extensively in zebrafish as a model 
for human tuberculosis infections caused by Mycobacterium tuberculosis (see (141-147) 




Figure A1: Adult zebrafish were injected intramuscularly with 106 CFU of S. agalactiae 
strain 515 or its isogenic ΔcpsA derivative.  Four hours post injection, fish were 
euthanized and spleens, hearts and brains were isolated.  Organs were homogenized 




pathogen in its own right.   As a human pathogen, M. marinum most often causes a 
granulomatous skin and soft tissue infection in fish hobbyists named “fish tank 
granuloma.”   This normally results from superficial wounding during routine fish tank 
maintenance.   Additionally, infections have been linked to swimming in contaminated 
aquatic environments (206, 207).  These infections can become severe requiring 
prolonged multi-antibiotic therapy and/or surgical interventions (206, 207).  In patients 
being treated with immunosuppressant drugs, these infections can be more prevalent 
and severe (208).  Superficial infection can rarely disseminate to bones and joints or 
cause a pulmonary infection (206, 207).  Mycobacteria are also natural pathogens of 
marine and freshwater fish (see (209, 210) for review and citations within).    
 Fish kept in aquaculture farms and zebrafish research colonies are susceptible to 
natural infection by several species of mycobacteria, including M. abscessus, M. 
chelonae, M. fortuitum, M. marinum, M. haemophilum and M. peregrinum.   Most 
species are opportunistic pathogens but M. marinum and M. haemophilum are highly 
pathogenic.  Bacteria are acquired from other infected fish or infected biofilm.  (for more 
extensive discussion see (211) and citations within).   
 To further examine the virulence of mycobacterial species isolated from research 
facilities Watral and Kent experimentally infected, by intraperitoneal injection, zebrafish 
with several strains of M. marinum, M. abscessus, M. peregrinum, and M. chelonae 
(212).   Only fish infected with M. marinum exhibited symptoms of disease and 
succumbed to infection.  However, histopathologic examination of infected fish found 
granulomatous lesions in the peritoneum, kidneys and ovaries of fish infected with M. 
marinum and non-marinum species, indicating that these fish can be sub-clinically 
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infected with mycobacteria.  Live bacteria were only consistently recovered from the fish 
infected with M. marinum, but some individual fish were asymptomatic carriers of other 
the other mycobacterial species.   Symptoms of M. marinum disease in experimentally 
infected fish were skin erythema, raised scales, swollen abdomens and rarely, skin 
lesions (212). 
  To study possible natural transmission routes, Peterson et al. (2013) examined 
inoculation of M. marinum and M. chelonae by the oro-gastric route by using the single 
cell eukaryotic cilliate Paramecium caudatum as a vector (213).    Larval, juvenile and 
adult fish exhibited more extragastric (mainly kidney and spleen) granulomas containing 
Mycobacteria when fed paramecia infected with M. marinum or M. chelonae than when 
the bacteria were incorporated into a food gel matrix or free bacteria were added to the 
water.  Gastrointestinal bacteria were observed for all infection routes, suggesting that 
bacteria are more virulent after passing through a cilliate host, and are better able to 
cause disseminated infection (213).  
 In many mycobacterial species the Type VII secretion system has been 
implicated in virulence.  To examine the effect of the M. marinum type VII protein 
secretion system ESX-5 in establishment of granulomas in zebrafish, Weerdenburg et 
al. (2012) used the zebrafish model.  Their analysis demonstrated that this protein 
secretion system serves a complex role in virulence (214).  When the ESX-5 mutant 
was microinjected into zebrafish larvae 28 hours post fertilization with 100 cfu into the 
caudal vein, establishment of initial infection was mildly attenuated compared to 
injection with the wild type strain.  Fewer bacteria were isolated from the infected larvae 
and granuloma formation was delayed in fish infected with the ESX-5 mutant than with 
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wild type bacteria.  However, adult fish infected with the ESX-5 mutant succumb more 
rapidly to infection and have higher bacterial loads in the spleen and lung than fish 
infected with wild type bacteria.   Since larvae do not yet have a functional adaptive 
immune system, the role of the adaptive immune system was examined to see if it was 
responsible for the discrepancy between attenuation in larvae and hypervirulence 
observed in adult fish.  However, infection with the ESX-5 mutant into Rag1 deficient 
adult fish, which are deficient in an adaptive immune response, showed that the 
hypervirulent phenotype was not depended on the adaptive immune system.  
Histopathologically, fish infected with the ESX-5 mutant bacteria developed granulomas 
sooner and in higher numbers than fish infected with wild type bacteria.   Additionally, 
pro-inflammatory cytokines (IL-1β, TNF-α and IFN-γ) were more highly expressed in 
ESX-5 granulomas.  Co-infection of wild type and ESX-5 bacteria, to determine if the 
secreted factors from the wild type could complement the hypervirulence of the ESX-5 
mutant, showed that the ESX-5 mutant outcompeted the wild type strain.  These results 
suggest that the ESX-5 protein secretion system functions to modulate M. marinum 
virulence and potentially contribute to persistence (214).  
 In addition to a type VII secretion system, the Sec2A alternative protein 
translocation system is another putative virulence factor of M. marinum. Sec2A mutants 
were attenuated in a larval zebrafish model of M. marinum infection (215).   Fish were 
infected by microinjection into the caudal vein 24 hours post fertilization.  Five days 
post-infection, bacterial loads were five times higher in fish infected with wild type than 
sec2A mutant bacteria.  Mutant bacteria showed less aggregation in larvae and 
leukocytes formed smaller and less compact aggregates in fish infected with mutant 
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bacteria.  Complementation of the sec2A mutation restored wild type levels of bacterial 
load and aggregation with leukocytes (215).   
 In an effort to develop a vaccine to control M. marinum infection, Cui et al. (2012) 
examined the effectiveness of an attenuated strain of M. marinum with reduced 
replication in macrophages.  In addition, heat killed M. marinum and extracellular 
secreted products were tested.  Results showed that while all three vaccination 
methods lead to the production of antibodies, only the live attenuated strain protected 
zebrafish from challenge with virulent M. marinum (216).  
3.5 Vibrios 
 Of the human pathogens that can be found in seawater environments, Vibrios 
are the predominant species (217).  Infection is most commonly acquired by wound 
contamination from exposure to contaminated water or aquatic organisms, the ingestion 
of contaminated water or consumption of raw or undercooked seafood (138). The 
clinical syndromes most commonly associated with Vibrio infection from aquatic 
environments are gastroenteritis, soft tissue infection and primary bacteremia (218).  
Soft tissue infections from wounds most commonly occur from recreational water 
activities such as swimming, surfing or boating, followed by fishing injuries and handling 
of seafood (219).  Although food borne infection is the most commonly recognized 
clinical syndrome from Vibrio aquatic exposure, soft tissue infections can result in high 
morbidity and mortality, leading the Centers of Disease Control and Prevention to 
recently add non-cholera vibriosis as a national notifiable disease (219).   
 For non-food borne Vibrio infections, Vibrio vulnificus is the most common 
aquatic-associated infections in humans, followed by Vibrio alginolyticus and Vibrio 
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parahemolyticus  (219).  All three of these organisms have been modeled in the 
zebrafish (220-223). 
3.5.1. Vibrio alginlyticus 
 Vibrio alginolyticus causes septicemia in fish, as well as gastrointistinal, wound 
and mucosal infections in humans.   To determine the role in pathogenesis in vivo of the 
twin-arginine translocation system (Tat) used by V. alginolyticus, He et al. (2011) 
utilized the zebrafish infectious disease model (171).  The Tat system is used by the 
bacterium for translocating folded proteins and secretion of specific virulence factors 
along with roles in growth and motility.  Construction and analysis of a strain deleted for 
the genes in the twin-arginine translocation system impacted biofilm formation and 
swarming motility and decreased secretion of extracellular proteases.  Loss of these 
functions resulted in a reduction in virulence in the zebrafish compared to infection with 
the wild type strain (171).  Similarly, Wang et al.. used the zebrafish model to analyze 
mutants in iron uptake systems by demonstrating that the TonB1 and TonB2 systems 
are also required for systemic virulence of V. alginolyticus.  Deletion of one locus 
resulted in an approximately one-log increase in LD50 and a double deletion resulted in 
over a 25-fold increase in LD50 (31).   
3.5.2 Vibrio vulnificus 
 Vibrio vulnificus causes the greatest majority of soft tissue infections from marine 
microorganisms (138).  However, the most lethal infection caused by V. vulnificus is 
primary septicemia, with a greater than 50% mortality rate (218). 
V. vulnificus infection of zebrafish is lethal and shows a specific increase of 
innate immunity genes following V. vulnificus infection (66).  Treatment of zebrafish with 
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the antimicrobial peptide epinecidin-1 from Grouper (Epinephelus coioides) is able to 
protect zebrafish from V. vulnificus infection.  Co-injection of epinecidin-1 conferred the 
best protection, but pre-treatment (one hour prior to injection of bacteria) or post-
treatment (one hour after bacterial injection) also conferred protection.  Fish surviving 
infection with epinecidin co-treatment were challenged again with bacteria 30 days post 
infection and had reduced mortality compared to naïve fish, indicating that epinecidin 
co-treatment acts similar to a live-attenuated vaccine.  Microarray analysis for 
inflammatory genes indicated that infection, epinecidin and co-treatment lead to distinct 
transcriptional changes.  Epinecidin is acting as both an antibacterial and 
immunomodulatory molecule to confer protection to V. vulnificus infection (66). 
3.5.3 Vibrio cholerae 
 Another Vibrio species that is responsible for a great deal of morbidity and 
mortality worldwide from consumption of contaminated seafood or water is Vibrio 
cholerae.  Disease from V. cholerae manifests mainly as a gastrointestinal pathogen, 
causing the disease of cholera, which leads to massive watery diarrhea resulting in 
dehydration and loss of electrolytes. Cholera afflicts an estimated 5 million people 
annually worldwide, causing over 100,000 deaths.  Without rehydration therapy, cholera 
is lethal in 50-60% of patients; however quick treatment results in less than 1% mortality 
(224).  
 Like other Vibrio species, V. cholerae can be found associated with aquatic 
organisms (shellfish, insect egg masses, and plankton) as well as free swimming in 
water (225-228).  Much research has been done on the human pathogenesis of V. 
cholerae, and recently there has been increased interest on the environmental lifestyle 
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and aquatic reservoirs of the organism, with hope of determining key factors required for 
transmission to humans.  Current animal models for V. cholerae include the infant 
mouse model (229), the rabbit intestinal ileal loop model (230-232).  Unfortunately, 
neither the mouse nor the rabbit are natural hosts for V. cholerae and therefore, do not 
mimic human disease.  Senderovich recently identified non-O1 V. cholerae in the 
intestinal tracts of multiple species of wild-caught fish (228), suggesting that V. cholerae 
may use vertebrate fish as an environmental reservoir, allowing for bacterial replication 
and transmission to water sources and other aquatic organisms.   
Not much is known about the environmental lifestyle of V. cholerae or the key factors 
required for the pathogen to survive for long periods in an aquatic environment.  Since 
previous mammalian models were not successful in reproducing human cholera 
symptoms, recent work investigated the efficacy of using the zebrafish host model as a 
model for cholera disease, and/or model as an environmental reservoir for V. cholerae 
(38). Runft et al. found that zebrafish gut could be highly colonized over long periods of 
time by pandemic O1 serogroup V. cholerae strains through simple addition of the 
bacteria to the water.  Furthermore, no prior manipulation of the natural intestinal flora is 
needed as is required with the other V. cholerae animal models, which suggests that 
colonization of the intestine in natural fish populations could easily occur with V. 
cholerae.  Histology of infected zebrafish intestines illustrated that V. cholerae was 
closely attached to the intestinal epithelium and formed many micro-colonies in this 
environment (38).  In an effort to mimic uptake of bacteria from both the water and the 
natural environment, providing a delivery vehicle of a contaminated food source was 
explored.  Zebrafish rapidly eat freshly hatched brine shrimp as a natural food source. 
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V. cholerae express chitin binding proteins and were found to bind readily to brine 
shrimp after a 15 minute incubation (Fig A2A and A2B).  Addition of contaminated brine 
shrimp to an experimental tank of zebrafish resulted in an initial increase in colonization 
by 2 logs at 2 hours post inoculation compared to water inoculated fish (Fig A2C).  
However, by 24 hours post infection, levels of V. cholerae in the intestine were actually 
lower than the water-inoculated fish. One possible explanation for this observation is 
that V. cholerae adhere directly to the feeding appendages of brine shrimp and, 
therefore, many of the V. cholerae are excreted by the fish without ever establishing 
colonization of the epithelial surface.  
One of the most interesting findings from this study was the ability of infected fish to 
pass the infection to naïve fish.  Zebrafish were placed in water contaminated with V. 
cholerae for 3 hours, followed by multiple washing steps.  An exposed fish was then 
placed into an experimental tank with fresh water and multiple naïve fish.  Importantly, 
previous work showed that V. cholerae cannot be isolated from the outer surface of the 
fish.  After 24 hours, the naïve fish population, exposed to the contaminated fish, was 
colonized with V. cholerae.  This type of disease transmission cannot be analyzed using 
the mammalian host models.   Moreover, this occurrence is very likely to happen in the 
natural environment and may be one way in which V. cholerae maintains its presence in 
an aquatic habitat, by transfer from host to host (38).   
 This new model for V. cholerae provides a more natural route of infection of any 
previous animal model.  Furthermore, it goes beyond most animal models as it provides 
a method for exploring the environmental lifestyle of the organism and transmission 






Figure A2: Brine shrimp cultures are produced using brine shrimp eggs (Artemia cysts) 
and a brine shrimp hatchery (Aquatic Eco-systems).  Freshly hatched brine shrimp (< 24 
hours post hatch) were removed from the hatchery and washed 3X in tap water to 
remove excess salt. One hundred microliters of washed brine shrimp were added to 1 
ml of 108 cfu of V. cholerae and mixed gently on a rotator for 15 minutes at room 
temperature.  A) uninfected shrimp B)infected shrimp C) Time course of colonization for 
fish infected after water exposure or using brine shrimp as a vehicle. Each dot 
represents the data from one fish and the horizontal bar indicates the mean bacterial 
load per fish. Total colonization per intestine was calculated after plating serial dilutions 




to be done to determine how colonization of the fish gut may prime the organism for 
infection of humans or allows the organism to maintain physiologically competent for 
transmission and subsequent infection of humans.  
4. Summary 
 The zebrafish infectious disease model has emerged as a highly useful tool for 
analyzing pathogenesis caused by a number of organisms.  More recently, analyses of 
aquatic pathogens in the zebrafish model have provided new information on how fish 
can act as environmental reservoirs for both human and aquatic infections. The 
zebrafish presents a perfect model in which to study these interactions because of its 
aquatic lifestyle as well as its ability to respond to infection that accurately mimics 
disease characteristics observed during human infections.  Aquatic pathogens can 
cause life-threatening soft tissue infections, food borne disease and bacteremia in 
humans as well as other aquatic species that are consumed or handled by humans. 
Here we focused on those pathogens that are found in the aquatic environment and 
serve as environmental reservoirs for infection of fish species and, importantly, as a 
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Streptococci are important human and animal pathogens.  Group B 
Streptococcus (GBS) is a zoonotic pathogen that is the leading cause of human 
neonatal sepsis and meningitis. In order to cause systemic disease GBS must produce 
a polysaccharide capsule. Capsule expression is controlled in part by the protein CpsA.  
We demonstrate that deletion of the cpsA gene, or expression of proteins with 
modifications to the extracellular or leucine zipper domains leads to reduced capsule 
expression and abnormalities in the bacterial cell wall and in cell division.  Capsule and 
cell wall/cell division phenotypes are also seen when modified proteins are expressed in 
a wild type bacterial strain, indicating the modified protein exerts a dominant negative 
effect. Additionally, we demonstrate that the dominant negative effect can act through 
addition of purified modified CpsA protein or synthetic CpsA-derived peptide to wild type 
cultures.  Further investigation of mutation of the lytR gene, which encodes for a protein 
related to CpsA, showed that LytR also has roles in bacterial capsule expression and 
cell wall/cell division phenotypes. Streptococcus pyogenes is a human pathogen that 
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causes a range of diseases from superficial to life threatening.  Peptide signaling serves 
important roles in many pathogenic bacterial species.  We demonstrate that the 
peptides encoded in the salivaricin locus by S. pyogenes, SalA and SalZ, have key 
roles in controlling virulence of S. pyogenes.  Data suggests that the SalA peptide acts 
synergistically with the two component signaling system also encoded in the sal locus, 
SalKR, in regulation of transcription and in survival in a model of septic infection.  The 
SalZ peptide was also shown to have roles in transcription of the sal locus and virulence 
of S. pyogenes.  Taken together, the work described here demonstrates key 






HANNAH MORRISON ROWE 
Education: 
 
Ph.D. Immunology Microbiology, Dec 2014 
School of Medicine, Wayne State University  
Detroit, MI. 
  
B.S. Microbiology, with Honors, May 2009 
College of Natural Sciences, Michigan State University 




H.M. Rowe, B.R. Hanson, D.L. Runft, Q. Lin, S.M. Firesteine, and M.N. Neely.  
Modification of the CpsA protein reveals a role in alterations of the Streptococcus 
agalatiae cell envelope. Infection and Immunity. In revision. 
 
H.M. Rowe,  J. H. Withey and M. N. Neely.  Zebrafish as a model for aquatic zoonotic 
pathogens.  Developmental and Comparative Immunology.  Sept 2014. 46 (1): 96–107. 
 
P. Namprachan-Frantz, H.M. Rowe, D.L. Runft and M.N. Neely. Transcriptional analysis 
of the Streptococcus pyogenes salivaricin locus.  Journal of Bacteriology.   Feb 2014. 
196(3):604-13 
 
 
 
 
